Plants and cells transformed with a nucleic acid from Bacillus thuringiensis strain KB59A4-6 encoding a novel SUP toxin

BACKGROUND OF THE INVENTION

Insects and other pests cost farmers billions of dollars annually in crop losses and in the expense of keeping these pests under control. The losses caused by insect pests in agricultural production environments include decrease in crop yield, reduced crop quality, and increased harvesting costs.

Cultivation methods, such as crop rotation and the application of high nitrogen levels to stimulate the growth of an adventitious root system, has partially addressed problems caused by agricultural pests. Economic demands on the utilization of farmland restrict the use of crop rotation. In addition, overwintering traits of some insects are disrupting crop rotations in some areas. Thus, chemical insecticides are relied upon most heavily to guarantee the desired level of control. Insecticides are either banded onto or incorporated into the soil.

The use of chemical insecticides has several drawbacks. Continual use of insecticides has allowed resistant insects to evolve. Situations such as extremely high populations of larvae, heavy rains, and improper calibration of insecticide application equipment can result in poor control. The use of insecticides often raises environmental concerns such as contamination of soil and of both surface and underground water supplies. The public has also become concerned about the amount of residual, synthetic chemicals which might be found on food. Working with insecticides may also pose hazards to the persons applying them. Therefore, synthetic chemical pesticides are being increasingly scrutinized, and correctly so, for their potential toxic environmental consequences. Examples of widely used synthetic chemical pesticides include the organochlorines, e.g., DDT, mirex, kepone, lindane, aldrin, chlordane, aldicarb, and dieldrin; the organophosphates, e.g., chlorpyrifos, parathion, malathion, and diazinon; and carbamates. Stringent new restrictions on the use of pesticides and the elimination of some effective pesticides from the market place could limit economical and effective options for controlling damaging and costly pests.

Because of the problems associated with the use of organic synthetic chemical pesticides, there exists a clear need to limit the use of these agents and a need to identify alternative control agents. The replacement of synthetic chemical pesticides, or combination of these agents with biological pesticides, could reduce the levels of toxic chemicals in the environment.

A biological pesticidal agent that is enjoying increasing popularity is the soil microbe

Bacillus thuringiensis

(

B.t

.). The soil microbe

Bacillus thuringiensis

(

B.t

.) is a Gram-positive, spore-forming bacterium. Most strains of

B.t

. do not exhibit pesticidal activity. Some

B.t

. strains produce, and can be characterized by, parasporal crystalline protein inclusions. These inclusions often appear microscopically as distinctively shaped crystals. Some

B.t

. proteins are highly toxic to pests, such as insects, and are specific in their toxic activity. Certain insecticidal

B.t

. proteins are associated with the inclusions. These “δ-endotoxins,” are different from exotoxins, which have a non-specific host range. Other species of Bacillus also produce pesticidal proteins.

Certain Bacillus toxin genes have been isolated and sequenced, and recombinant DNA-based products have been produced and approved for use. In addition, with the use of genetic engineering techniques, new approaches for delivering these toxins to agricultural environments are under development. These include the use of plants genetically engineered with toxin genes for insect resistance and the use of stabilized intact microbial cells as toxin delivery vehicles. Thus, isolated Bacillus toxin genes are becoming commercially valuable.

Until the last fifteen years, commercial use of

B.t

. pesticides has been largely restricted to targeting a narrow range of lepidopteran (caterpillar) pests. Preparations of the spores and crystals of

B. thuringiensis

subsp.

kurstaki

have been used for many years as commercial insecticides for lepidopteran pests. For example,

B. thuringiensis

var.

kurstaki

HD-1 produces a crystalline δ-endotoxin which is toxic to the larvae of a number of lepidopteran insects.

In recent years, however, investigators have discovered

B.t

. pesticides with specificities for a much broader range of pests. For example, other species of

B.t

., namely

israelensis

and

morrisoni

(a.k.a.

tenebrionis

, a.k.a.

B.t

. M-7, a.k.a.

B.t

. san diego), have been used commercially to control insects of the orders Diptera and Coleoptera, respectively.

Bacillus thuringiensis

var.

tenebrionis

has been reported to be active against two beetles in the order Coleoptera (Colorado potato beetle,

Leptinotarsa decemlineata

, and

Agelastica alni

).

More recently, new subspecies of

B.t

. have been identified, and genes responsible for active δ-endotoxin proteins have been isolated. Höfte and Whiteley classified

B.t

. crystal protein genes into four major classes (Höfte, H., H. R. Whiteley [1989

]

Microbiological Reviews

52(2):242-255). The classes were CryI (Lepidoptera-specific), CryII (Lepidoptera- and Diptera-specific), CryIII (Coleoptera-specific), and CryIV (Diptera-specific). The discovery of strains specifically toxic to other pests has been reported. For example, CryV and CryVI have been proposed to designate a class of toxin genes that are nematode-specific.

The 1989 nomenclature and classification scheme of Höfte and Whiteley for crystal proteins was based on both the deduced amino acid sequence and the host range of the toxin. That system was adapted to cover 14 different types of toxin genes which were divided into five major classes. The number of sequenced

Bacillus thuringiensis

crystal protein genes currently stands at more than 50. A revised nomenclature scheme has been proposed which is based solely on amino acid identity (Crickmore et al. [1996] Society for Invertebrate Pathology, 29th Annual Meeting, IIIrd International Colloquium on

Bacillus thuringiensis

, University of Cordoba, Cordoba, Spain, Sep. 1-6, 1996, abstract). The mnemonic “cry” has been retained for all of the toxin genes except cytA and cytB, which remain a separate class. Roman numerals have been exchanged for Arabic numerals in the primary rank, and the parentheses in the tertiary rank have been removed. Many of the original names have been retained, with the noted exceptions, although a number have been reclassified.

Many other

B.t

. genes have now been identified. WO 94/21795, WO 96/10083, WO 98/44137, and Estruch, J. J. et al. (1996) PNAS 93:5389-5394 describe Vip1A(a), Vip1A(b), Vip2A(a), Vip2A(b), Vip3A(a), and Vip3A(b) toxins obtained from Bacillus microbes. Those toxins are reported to be produced during vegetative cell growth and were thus termed vegetative insecticidal proteins (VIP). Activity of these toxins against certain lepidopteran and certain coleopteran pests was reported. WO 98/18932 discloses new classes of pesticidal toxins.

Obstacles to the successful agricultural use of Bacillus toxins include the development of resistance to

B.t

. toxins by insects. In addition, certain insects can be refractory to the effects of Bacillus toxins. The latter includes insects such as boll weevil and black cutworm as well as adult insects of most species which heretofore have demonstrated no apparent significant sensitivity to

B.t

. δ-endotoxins. While resistance management strategies in

B.t

. transgene plant technology have become of great interest, there remains a great need for developing additional genes that can be expressed in plants in order to effectively control various insects.

The subject application provides new classes of toxins and genes, in addition to those described in WO 98/18932, and which are distinct from those disclosed in WO 94/21795, WO 96/10083, WO 98/44137, and Estruch et al.

BRIEF SUMMARY OF THE INVENTION

The subject invention concerns materials and methods useful in the control of non-mammalian pests and, particularly, plant pests. In one embodiment, the subject invention provides novel Bacillus isolates having advantageous activity against non-mammalian pests. In a further embodiment, the subject invention provides new toxins useful for the control of non-mammalian pests. In a preferred embodiment, these pests are lepidopterans and/or coleopterans. The toxins of the subject invention include δ-endotoxins as well as soluble toxins which can be obtained from the supernatant of Bacillus cultures.

The subject invention further provides nucleotide sequences which encode the toxins of the subject invention. The subject invention further provides nucleotide sequences and methods useful in the identification and characterization of genes which encode pesticidal toxins.

In one embodiment, the subject invention concerns unique nucleotide sequences which are useful as hybridization probes and/or primers in PCR techniques. The primers produce characteristic gene fragments which can be used in the identification, characterization, and/or isolation of specific toxin genes. The nucleotide sequences of the subject invention encode toxins which are distinct from previously-described toxins.

In a specific embodiment, the subject invention provides new classes of toxins having advantageous pesticidal activities. These classes of toxins can be encoded by polynucleotide sequences which are characterized by their ability to hybridize with certain exemplified sequences and/or by their ability to be amplified by PCR using certain exemplified primers.

One aspect of the subject invention pertains to the identification and characterization of entirely new families of Bacillus toxins having advantageous pesticidal properties. The subject invention includes new classes of genes and toxins referred to herein as MIS-7 and MIS-8. Genes and toxins of novel WAR- and SUP-classes are also disclosed. Certain MIS-1 and MIS-2 toxins and genes are also further characterized herein.

These families of toxins, and the genes which encode them, can be characterized in terms of, for example, the size of the toxin or gene, the DNA or amino acid sequence, pesticidal activity, and/or antibody reactivity. With regard to the genes encoding the novel toxin families of the subject invention, the current disclosure provides unique hybridization probes and PCR primers which can be used to identify and characterize DNA within each of the exemplified families.

In one embodiment of the subject invention, Bacillus isolates can be cultivated under conditions resulting in high multiplication of the microbe. After treating the microbe to provide single-stranded genomic nucleic acid, the DNA can be contacted with the primers of the invention and subjected to PCR amplification. Characteristic fragments of toxin-encoding genes will be amplified by the procedure, thus identifying the presence of the toxin-encoding gene(s).

A further aspect of the subject invention is the use of the disclosed nucleotide sequences as probes to detect genes encoding Bacillus toxins which are active against pests.

Further aspects of the subject invention include the genes and isolates identified using the methods and nucleotide sequences disclosed herein. The genes thus identified encode toxins active against pests. Similarly, the isolates will have activity against these pests. In a preferred embodiment, these pests are lepidopteran or coleopteran pests.

In a preferred embodiment, the subject invention concerns plants cells transformed with at least one polynucleotide sequence of the subject invention such that the transformed plant cells express pesticidal toxins in tissues consumed by target pests. As described herein, the toxins useful according to the subject invention may be chimeric toxins produced by combining portions of multiple toxins. In addition, mixtures and/or combinations of toxins can be used according to the subject invention.

Transformation of plants with the genetic constructs disclosed herein can be accomplished using techniques well known to those skilled in the art and would typically involve modification of the gene to optimize expression of the toxin in plants.

Alternatively, the Bacillus isolates of the subject invention, or recombinant microbes expressing the toxins described herein, can be used to control pests. In this regard, the invention includes the treatment of substantially intact Bacillus cells, and/or recombinant cells containing the expressed toxins of the invention, treated to prolong the pesticidal activity when the substantially intact cells are applied to the environment of a target pest. The treated cell acts as a protective coating for the pesticidal toxin. The toxin becomes active upon ingestion by a target insect.

BRIEF DESCRIPTION OF THE SEQUENCES

SEQ ID NO. 1 is a nucleotide sequence encoding a toxin from

B.t

. strain Javelin 1990.

SEQ ID NO. 2 is an amino acid sequence for the Javelin 1990 toxin.

SEQ ID NO. 3 is a forward primer used according to the subject invention.

SEQ ID NO. 4 is a reverse primer used according to the subject invention.

SEQ ID NO. 5 is a nucleotide sequence of a toxin gene from

B.t

. strain PS66D3

SEQ ID NO. 6 is an amino acid sequence from the 66D3 toxin.

SEQ ID NO. 7 is a nucleotide sequence of a MIS toxin gene from

B.t

. strain PS177C8.

SEQ ID NO. 8 is an amino acid sequence from the 177C8-MIS toxin.

SEQ ID NO. 9 is a nucleotide sequence of a toxin gene from

B.t

. strain PS177I8

SEQ ID NO. 10 is an amino acid sequence from the 177I8 toxin.

SEQ ID NO. 11 is a nucleotide sequence encoding a 177C8-WAR toxin gene from

B.t

. strain PS177C8.

SEQ ID NO. 12 is an amino acid sequence of a 177C8-WAR toxin from

B.t

. strain PS177C8.

SEQ ID NOS. 13-21 are primers used according to the subject invention.

SEQ ID NO. 22 is the reverse complement of the primer of SEQ ID NO. 14.

SEQ ID NO. 23 is the reverse complement of the primer of SEQ ID NO. 15.

SEQ ID NO. 24 is the reverse complement of the primer of SEQ ID NO. 17.

SEQ ID NO. 25 is the reverse complement of the primer of SEQ ID NO. 18.

SEQ ID NO. 26 is the reverse complement of the primer of SEQ ID NO. 19.

SEQ ID NO. 27 is the reverse complement of the primer of SEQ ID NO. 20.

SEQ ID NO. 28 is the reverse complement of the primer of SEQ ID NO. 21.

SEQ ID NO. 29 is a MIS-7 forward primer.

SEQ ID NO. 30 is a MIS-7 reverse primer.

SEQ ID NO. 31 is a MIS-8 forward primer.

SEQ ID NO. 32 is a MIS-8 reverse primer.

SEQ ID NO. 33 is a nucleotide sequence of a MIS-7 toxin gene designated 157C1-A from

B.t

. strain PS157C1.

SEQ ID NO. 34 is an amino acid sequence of a MIS-7 toxin designated 157C1-A from

B.t

. strain PS157C1.

SEQ ID NO. 35 is a nucleotide sequence of a MIS-7 toxin gene from

B.t

. strain PS201Z.

SEQ ID NO. 36 is a nucleotide sequence of a MIS-8 toxin gene from

B.t

. strain PS31F2.

SEQ ID NO. 37 is a nucleotide sequence of a MIS-8 toxin gene from

B.t

. strain PS185Y2.

SEQ ID NO. 38 is a nucleotide sequence of a MIS-1 toxin gene from

B.t

. strain PS33F1.

SEQ ID NO. 39 is a MIS primer for use according to the subject invention.

SEQ ID NO. 40 is a MIS primer for use according to the subject invention.

SEQ ID NO. 41 is a WAR primer for use according to the subject invention.

SEQ ID NO. 42 is a WAR primer for use according to the subject invention.

SEQ ID NO. 43 is a partial nucleotide sequence for a MIS-7 gene from PS205C.

SEQ ID NO. 44 is a partial amino acid sequence for a MIS-7 toxin from PS205C.

SEQ ID NO. 45 is a partial nucleotide sequence for a WAR gene from PS205C.

SEQ ID NO. 46 is a partial amino acid sequence for a WAR toxin from PS205C.

SEQ ID NO. 47 is a nucleotide sequence for a MIS-8 gene from PS31F2.

SEQ ID NO. 48 is an amino acid sequence for a MIS-8 toxin from PS31F2.

SEQ ID NO. 49 is a nucleotide sequence for a WAR gene from PS31F2.

SEQ ID NO. 50 is an amino acid sequence for a WAR toxin from PS31F2.

SEQ ID NO. 51 is a SUP primer for use according to the subject invention.

SEQ ID NO. 52 is a SUP primer for use according to the subject invention.

SEQ ID NO. 53 is a nucleotide sequence for a SUP gene from KB59A4-6.

SEQ ID NO. 54 is an amino acid sequence for a SUP toxin from KB59A4-6.

DETAILED DISCLOSURE OF THE INVENTION

The subject invention concerns materials and methods for the control of non-mammalian pests. In specific embodiments, the subject invention pertains to new

Bacillus thuringiensis

isolates and toxins which have activity against lepidopterans and/or coleopterans. The subject invention further concerns novel genes which encode pesticidal toxins and novel methods for identifying and characterizing Bacillus genes which encode toxins with useful properties. The subject invention concerns not only the polynucleotide sequences which encode these toxins, but also the use of these polynucleotide sequences to produce recombinant hosts which express the toxins. The proteins of the subject invention are distinct from protein toxins which have previously been isolated from

Bacillus thuringiensis.

B.t

. isolates useful according to the subject invention have been deposited in the permanent collection of the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, Ill. 61604, USA. The culture repository numbers of the

B.t

. strains are as follows:

TABLE 1

Culture

Repository No.

Deposit Date

Patent No.

B.t. PS157C1 (MT104)

NRRL B-18240

Jul. 17, 1987

5,262,159

B.t. PS31F2

NRRL B-21876

Oct. 24, 1997

B.t. PS66D3

NRRL B-21858

Oct. 24, 1997

B.t. PS177C8a

NRRL B-21867

Oct. 24, 1997

B.t. PS177I8

NRRL B-21868

Oct. 24, 1997

KB53A49-4

NRRL B-21879

Oct. 24, 1997

KB68B46-2

NRRL B-21877

Oct. 24, 1997

KB68B51-2

NRRL B-21880

Oct. 24, 1997

KB68B55-2

NRRL B-21878

Oct. 24, 1997

PS33F1

NRRL B-21977

Apr. 24, 1998

PS71G4

NRRL B-21978

Apr. 24, 1998

PS86D1

NRRL B-21979

Apr. 24, 1998

5185V2

NRRL B-21980

Apr. 24, 1998

S191A21

NRRL B-21981

Apr. 24, 1998

P5201Z

NRRL B-21982

Apr. 24, 1998

PS205A3

NRRL B-21983

Apr. 24, 1998

PS205C

NRRL B-21984

Apr. 24, 1998

PS234E1

NRRL B-21985

Apr. 24, 1998

P5248N10

NRRL B-21986

Apr. 24, 1998

KB63B19-13

NRRL B-21990

Apr. 29, 1998

KB63B19-7

NRRL B-21989

Apr. 29, 1998

KB68B62-7

NRRL B-21991

Apr. 29, 1998

KB68B63-2

NRRL B-21992

Apr. 29, 1998

KB69A125-1

NRRL B-21993

Apr. 29, 1998

KB69A125-3

NRRL B-21994

Apr. 29, 1998

KB69A125-5

NRRL B-21995

Apr. 29, 1998

KB69A127-7

NRRL B-21996

Apr. 29, 1998

KB69A132-1

NRRL B-21997

Apr. 29, 1998

KB69B2-1

NRRL B-21998

Apr. 29, 1998

KB70B5-3

NRRL B-21999

Apr. 29, 1998

KB71A125-15

NRRL B-30001

Apr. 29, 1998

KB71A35-6

NRRL B-30000

Apr. 29, 1998

KB71A72-1

NRRL B-21987

Apr. 29, 1998

KB71A134-2

NRRL B-21988

Apr. 29, 1998

P5185Y2

NRRL B-30121

May 4, 1999

KBS9A4-6

NRRL B-30173

Aug. 5, 1999

MR992

NRRL B-30124

May 4, 1999

MR983

NRRL B-30123

May 4, 1999

MR993

NRRL B-30125

May 4, 1999

MR951

NRRL B-30122

May 4, 1999

Cultures which have been deposited for the purposes of this patent application were deposited under conditions that assure that access to the cultures is available during the pendency of this patent application to one determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37 CFR 1.14 and 35 U.S.C. 122. The deposits will be available as required by foreign patent laws in countries wherein counterparts of the subject application, or its progeny, are filed. However, it should be understood that the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by governmental action.

Further, the subject culture deposits will be stored and made available to the public in accord with the provisions of the Budapest Treaty for the Deposit of Microorganisms, i.e., they will be stored with all the care necessary to keep them viable and uncontaminated for a period of at least five years after the most recent request for the furnishing of a sample of the deposit, and in any case, for a period of at least thirty (30) years after the date of deposit or for the enforceable life of any patent which may issue disclosing the culture(s). The depositor acknowledges the duty to replace the deposit(s) should the depository be unable to furnish a sample when requested, due to the condition of a deposit. All restrictions on the availability to the public of the subject culture deposits will be irrevocably removed upon the granting of a patent disclosing them.

Many of the strains useful according to the subject invention are readily available by virtue of the issuance of patents disclosing these strains or by their deposit in public collections or by their inclusion in commercial products. For example, the

B.t

. strain used in the commercial product, Javelin, and the HD isolates are all publicly available.

Mutants of the isolates referred to herein can be made by procedures well known in the art. For example, an asporogenous mutant can be obtained through ethylmethane sulfonate (EMS) mutagenesis of an isolate. The mutants can be made using ultraviolet light and nitrosoguanidine by procedures well known in the art.

In one embodiment, the subject invention concerns materials and methods including nucleotide primers and probes for isolating, characterizing, and identifying Bacillus genes encoding protein toxins which are active against non-mammalian pests. The nucleotide sequences described herein can also be used to identify new pesticidal Bacillus isolates. The invention further concerns the genes, isolates, and toxins identified using the methods and materials disclosed herein.

The new toxins and polynucleotide sequences provided here are defined according to several parameters. One characteristic of the toxins described herein is pesticidal activity. In a specific embodiment, these toxins have activity against coleopteran and/or lepidopteran pests. The toxins and genes of the subject invention can be further defined by their amino acid and nucleotide sequences. The sequences of the molecules can be defined in terms of homology to certain exemplified sequences as well as in terms of the ability to hybridize with, or be amplified by, certain exemplified probes and primers. The toxins provided herein can also be identified based on their immunoreactivity with certain antibodies.

An important aspect of the subject invention is the identification and characterization of new families of Bacillus toxins, and genes which encode these toxins. These families have been designated MIS-7 and MIS-8. New WAR- and SUP-type toxin families are also disclosed herein. Toxins within these families, as well as genes encoding toxins within these families, can readily be identified as described herein by, for example, size, amino acid or DNA sequence, and antibody reactivity. Amino acid and DNA sequence characteristics include homology with exemplified sequences, ability to hybridize with DNA probes, and ability to be amplified with specific primers.

A gene and toxin (which are obtainable from PS33F1) of the MIS-1 family and a gene and toxin (which are obtainable from PS66D3) of the MIS-2 family are also further characterized herein.

A novel family of toxins identified herein is the MIS-7 family. This family includes toxins which can be obtained from

B.t

. isolates PS157C1, PS205C, and PS201Z. The subject invention further provides probes and primers for identification of the MIS-7 genes and toxins.

A further, novel family of toxins identified herein is the MIS-8 family. This family includes toxins which can be obtained from

B.t

. isolates PS31F2 and PS185Y2. The subject invention further provides probes and primers for identification of the MIS-8 genes and toxins.

In a preferred embodiment, the genes of the MIS family encode toxins having a molecular weight of about 70 to about 100 kDa and, most preferably, the toxins have a size of about 80 kDa. Typically, these toxins are soluble and can be obtained from the supernatant of Bacillus cultures as described herein. These toxins have toxicity against non-mammalian pests. In a preferred embodiment, these toxins have activity against coleopteran pests. The MIS proteins are further useful due to their ability to form pores in cells. These proteins can be used with second entities including, for example, other proteins. When used with a second entity, the MIS protein will facilitate entry of the second agent into a target cell. In a preferred embodiment, the MIS protein interacts with MIS receptors in a target cell and causes pore formation in the target cell. The second entity may be a toxin or another molecule whose entry into the cell is desired.

The subject invention further concerns a family of toxins designated WAR-type toxins. The WAR toxins typically have a size of about 30-50 kDa and, most typically, have a size of about 40 kDa. Typically, these toxins are soluble and can be obtained from the supernatant of Bacillus cultures as described herein. The WAR toxins can be identified with primers described herein as well as with antibodies.

An additional family of toxins provided according to the subject invention are the toxins designated SUP-type toxins. Typically, these toxins are soluble and can be obtained from the supernatant of Bacillus cultures as described herein. In a preferred embodiment, the SUP toxins are active against lepidopteran pests. The SUP toxins typically have a size of about 70-100 kDa and, preferably, about 80 kDa. The SUP family is exemplified herein by toxins from isolate KB59A4-6. The subject invention provides probes and primers useful for the identification of toxins and genes in the SUP family.

The subject invention also provides additional Bacillus toxins and genes, including additional MIS, WAR, and SUP toxins and genes.

Toxins in the MIS, WAR, and SUP families are all soluble and can be obtained as described herein from the supernatant of Bacillus cultures. These toxins can be used alone or in combination with other toxins to control pests. For example, toxins from the MIS families may be used in conjunction with WAR-type toxins to achieve control of pests, particularly coleopteran pests. These toxins may be used, for example, with δ-endotoxins which are obtained from Bacillus isolates.

Table 2 provides a summary of the novel families of toxins and genes of the subject invention. Certain MIS families are specifically exemplified herein by toxins which can be obtained from particular

B.t

. isolates as shown in Table 2. Genes encoding toxins in each of these families can be identified by a variety of highly specific parameters, including the ability to hybridize with the particular probes set forth in Table 2. Sequence identity in excess of about 80% with the probes set forth in Table 2 can also be used to identify the genes of the various families. Also exemplified are particular primer pairs which can be used to amplify the genes of the subject invention. A portion of a gene within the indicated families would typically be amplifiable with at least one of the enumerated primer pairs. In a preferred embodiment, the amplified portion would be of approximately the indicated fragment size. Primers shown in Table 2 consist of polynucleotide sequences which encode peptides as shown in the sequence listing attached hereto. Additional primers and probes can readily be constructed by those skilled in the art such that alternate polynucleotide sequences encoding the same amino acid sequences can be used to identify and/or characterize additional genes encoding pesticidal toxins. In a preferred embodiment, these additional toxins, and their genes, could be obtained from Bacillus isolates.

TABLE 2

Probes

Fragment

(SEQ ID

Primer Pairs

size

Family

Isolates

NO.)

(SEQ ID NOS.)

(nt)

MIS-1

PS33F1

37

13 and 22

69

13 and 23

506

14 and 23

458

MIS-2

PS66D3

5

16 and 24

160

16 and 25

239

16 and 26

400

16 and 27

509

16 and 28

703

17 and 25

102

17 and 26

263

17 and 27

372

17 and 28

566

18 and 26

191

18 and 27

300

18 and 28

494

19 and 27

131

19 and 28

325

20 and 28

213

MIS-7

PS205C, PS157C1

33, 35

29 and 30

598

(157C1-A), PS201Z

MIS-8

PS31F2, PS185Y2

36, 37

31 and 32

585

SUP

KB59A4-6

1

51 and 52

Furthermore, chimeric toxins may be used according to the subject invention. Methods have been developed for making useful chimeric toxins by combining portions of

B.t

. proteins. The portions which are combined need not, themselves, be pesticidal so long as the combination of portions creates a chimeric protein which is pesticidal. This can be done using restriction enzymes, as described in, for example, European Patent 0 228 838; Ge, A. Z., N. L. Shivarova, D. H. Dean (1989)

Proc. Natl. Acad. Sci. USA

86:4037-4041; Ge, A. Z., D. Rivers, R. Milne, D. H. Dean (1991)

J. Biol. Chem

. 266:17954-17958; Schnepf, H. E., K. Tomczak, J. P. Ortega, H. R. Whiteley (1990)

J. Biol. Chem

. 265:20923-20930; Honee, G., D. Convents, J. Van Rie, S. Jansens, M. Peferoen, B. Visser (1991)

Mol. Microbiol

. 5:2799-2806. Alternatively, recombination using cellular recombination mechanisms can be used to achieve similar results. See, for example, Caramori, T., A. M. Albertini, A. Galizzi (1991)

Gene

98:37-44; Widner, W. R., H. R. Whiteley (1990)

J. Bacteriol

. 172:2826-2832; Bosch, D., B. Schipper, H. van der Kliej, R. A. de Maagd, W. J. Stickema (1994)

Biotechnology

12:915-918. A number of other methods are known in the art by which such chimeric DNAs can be made. The subject invention is meant to include chimeric proteins that utilize the novel sequences identified in the subject application.

With the teachings provided herein, one skilled in the art could readily produce and use the various toxins and polynucleotide sequences described herein.

Genes and toxins. The genes and toxins useful according to the subject invention include not only the full length sequences but also fragments of these sequences, variants, mutants, and fusion proteins which retain the characteristic pesticidal activity of the toxins specifically exemplified herein. Chimeric genes and toxins, produced by combining portions from more than one Bacillus toxin or gene, may also be utilized according to the teachings of the subject invention. As used herein, the terms “variants” or “variations” of genes refer to nucleotide sequences which encode the same toxins or which encode equivalent toxins having pesticidal activity. As used herein, the term “equivalent toxins” refers to toxins having the same or essentially the same biological activity against the target pests as the exemplified toxins. For example, U.S. Pat. No. 5,605,793 describes methods for generating additional molecular diversity by using DNA reassembly after random fragmentation.

It is apparent to a person skilled in this art that genes encoding active toxins can be identified and obtained through several means. The specific genes exemplified herein may be obtained from the isolates deposited at a culture depository as described above. These genes, or portions or variants thereof, may also be constructed synthetically, for example, by use of a gene synthesizer. Variations of genes may be readily constructed using standard techniques for making point mutations. Also, fragments of these genes can be made using commercially available exonucleases or endonucleases according to standard procedures. For example, enzymes such as Bal31 or site-directed mutagenesis can be used to systematically cut off nucleotides from the ends of these genes. Also, genes which encode active fragments may be obtained using a variety of restriction enzymes. Proteases may be used to directly obtain active fragments of these toxins.

Equivalent toxins and/or genes encoding these equivalent toxins can be derived from Bacillus isolates and/or DNA libraries using the teachings provided herein. There are a number of methods for obtaining the pesticidal toxins of the instant invention. For example, antibodies to the pesticidal toxins disclosed and claimed herein can be used to identify and isolate toxins from a mixture of proteins. Specifically, antibodies may be raised to the portions of the toxins which are most constant and most distinct from other Bacillus toxins. These antibodies can then be used to specifically identify equivalent toxins with the characteristic activity by immunoprecipitation, enzyme linked immunosorbent assay (ELISA), or Western blotting. Antibodies to the toxins disclosed herein, or to equivalent toxins, or fragments of these toxins, can readily be prepared using standard procedures in this art. The genes which encode these toxins can then be obtained from the microorganism.

Fragments and equivalents which retain the pesticidal activity of the exemplified toxins are within the scope of the subject invention. Also, because of the redundancy of the genetic code, a variety of different DNA sequences can encode the amino acid sequences disclosed herein. It is well within the skill of a person trained in the art to create these alternative DNA sequences encoding the same, or essentially the same, toxins. These variant DNA sequences are within the scope of the subject invention. As used herein, reference to “essentially the same” sequence refers to sequences which have amino acid substitutions, deletions, additions, or insertions which do not materially affect pesticidal activity. Fragments retaining pesticidal activity are also included in this definition.

A further method for identifying the toxins and genes of the subject invention is through the use of oligonucleotide probes. These probes are detectable nucleotide sequences. Probes provide a rapid method for identifying toxin-encoding genes of the subject invention. The nucleotide segments which are used as probes according to the invention can be synthesized using a DNA synthesizer and standard procedures.

Certain toxins of the subject invention have been specifically exemplified herein. Since these toxins are merely exemplary of the toxins of the subject invention, it should be readily apparent that the subject invention comprises variant or equivalent toxins (and nucleotide sequences coding for equivalent toxins) having the same or similar pesticidal activity of the exemplified toxin. Equivalent toxins will have amino acid homology with an exemplified toxin. This amino acid identity will typically be greater than 60%, preferably be greater than 75%, more preferably greater than 80%, more preferably greater than 90%, and can be greater than 95%. These identities are as determined using standard alignment techniques. The amino acid homology will be highest in critical regions of the toxin which account for biological activity or are involved in the determination of three-dimensional configuration which ultimately is responsible for the biological activity. In this regard, certain amino acid substitutions are acceptable and can be expected if these substitutions are in regions which are not critical to activity or are conservative amino acid substitutions which do not affect the three-dimensional configuration of the molecule. For example, amino acids may be placed in the following classes: non-polar, uncharged polar, basic, and acidic. Conservative substitutions whereby an amino acid of one class is replaced with another amino acid of the same type fall within the scope of the subject invention so long as the substitution does not materially alter the biological activity of the compound. Table 3 provides a listing of examples of amino acids belonging to each class.

TABLE 3

Class of Amino Acid

Examples of Amino Acids

Nonpolar

Ala, Val, Leu, Ile, Pro, Met, Phe, Trp

Uncharged Polar

Gly, Ser, Thr, Cys, Tyr, Asn, Gln

Acidic

Asp, Glu

Basic

Lys, Arg, His

In some instances, non-conservative substitutions can also be made. The critical factor is that these substitutions must not significantly detract from the biological activity of the toxin.

The δ-endotoxins of the subject invention can also be characterized in terms of the shape and location of toxin inclusions, which are described above.

As used herein, reference to “isolated” polynucleotides and/or “purified” toxins refers to these molecules when they are not associated with the other molecules with which they would be found in nature. Thus, reference to “isolated and purified” signifies the involvement of the “hand of man” as described herein. Chimeric toxins and genes also involve the “hand of man.”

Recombinant hosts. The toxin-encoding genes of the subject invention can be introduced into a wide variety of microbial or plant hosts. Expression of the toxin gene results, directly or indirectly, in the production and maintenance of the pesticide. With suitable microbial hosts, e.g., Pseudomonas, the microbes can be applied to the situs of the pest, where they will proliferate and be ingested. The result is a control of the pest. Alternatively, the microbe hosting the toxin gene can be killed and treated under conditions that prolong the activity of the toxin and stabilize the cell. The treated cell, which retains the toxic activity, then can be applied to the environment of the target pest.

Where the Bacillus toxin gene is introduced via a suitable vector into a microbial host, and said host is applied to the environment in a living state, it is essential that certain host microbes be used. Microorganism hosts are selected which are known to occupy the “phytosphere” (phylloplane, phyllosphere, rhizosphere, and/or rhizoplane) of one or more crops of interest. These microorganisms are selected so as to be capable of successfully competing in the particular environment (crop and other insect habitats) with the wild-type microorganisms, provide for stable maintenance and expression of the gene expressing the polypeptide pesticide, and, desirably, provide for improved protection of the pesticide from environmental degradation and inactivation.

A large number of microorganisms are known to inhabit the phylloplane (the surface of the plant leaves) and/or the rhizosphere (the soil surrounding plant roots) of a wide variety of important crops. These microorganisms include bacteria, algae, and fungi. Of particular interest are microorganisms, such as bacteria, e.g., genera Pseudomonas, Erwinia, Serratia, Klebsiella, Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylophilius, Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, and Alcaligenes; fungi, particularly yeast, e.g., genera Saccharomyces, Cryptococcus, Kluyveromyces, Sporobolomyces, Rhodtorula, and Aureobasidium. Of particular interest are such phytosphere bacterial species as

Pseudomonas syringae, Pseudomonas fluorescens, Serratia marcescens, Acetobacter xylinum, Agrobacterium tumefaciens, Rhodopseudomonas spheroides, Xanthomonas campestris, Rhizobium melioti, Alcaligenes entrophus

, and

Azotobacter vinlandii

; and phytosphere yeast species such as

Rhodotorula rubra, R. glutinis, R. marina, R. aurantiaca, Cryptococcus albidus, C. diffluens, C. laurentii, Saccharomyces rosei, S. pretoriensis, S. cerevisiae, Sporobolomyces roseus, S. dorus, Kluyveromyces veronae

, and

Aureobasidium pollulans

. Of particular interest are the pigmented microorganisms.

A wide variety of ways are available for introducing a Bacillus gene encoding a toxin into a microorganism host under conditions which allow for stable maintenance and expression of the gene. These methods are well known to those skilled in the art and are described, for example, in U.S. Pat. No. 5,135,867, which is incorporated herein by reference.

Synthetic genes which are functionally equivalent to the toxins of the subject invention can also be used to transform hosts. Methods for the production of synthetic genes can be found in, for example, U.S. Pat. No. 5,380,831.

Treatment of cells. As mentioned above, Bacillus or recombinant cells expressing a Bacillus toxin can be treated to prolong the toxin activity and stabilize the cell. The pesticide microcapsule that is formed comprises the Bacillus toxin within a cellular structure that has been stabilized and will protect the toxin when the microcapsule is applied to the environment of the target pest. Suitable host cells may include either prokaryotes or eukaryotes. As hosts, of particular interest will be the prokaryotes and the lower eukaryotes, such as fungi. The cell will usually be intact and be substantially in the proliferative form when treated, rather than in a spore form.

Treatment of the microbial cell, e.g., a microbe containing the Bacillus toxin gene, can be by chemical or physical means, or by a combination of chemical and/or physical means, so long as the technique does not deleteriously affect the properties of the toxin, nor diminish the cellular capability of protecting the toxin. Methods for treatment of microbial cells are disclosed in U.S. Pat. Nos. 4,695,455 and 4,695,462, which are incorporated herein by reference.

Methods and formulations for control of pests. Control of pests using the isolates, toxins, and genes of the subject invention can be accomplished by a variety of methods known to those skilled in the art. These methods include, for example, the application of Bacillus isolates to the pests (or their location), the application of recombinant microbes to the pests (or their locations), and the transformation of plants with genes which encode the pesticidal toxins of the subject invention. Transformations can be made by those skilled in the art using standard techniques. Materials necessary for these transformations are disclosed herein or are otherwise readily available to the skilled artisan.

Formulated bait granules containing an attractant and the toxins of the Bacillus isolates, or recombinant microbes comprising the genes obtainable from the Bacillus isolates disclosed herein, can be applied to the soil. Formulated product can also be applied as a seed-coating or root treatment or total plant treatment at later stages of the crop cycle. Plant and soil treatments of Bacillus cells may be employed as wettable powders, granules or dusts, by mixing with various inert materials, such as inorganic minerals (phyllosilicates, carbonates, sulfates, phosphates, and the like) or botanical materials (powdered corncobs, rice hulls, walnut shells, and the like). The formulations may include spreader-sticker adjuvants, stabilizing agents, other pesticidal additives, or surfactants. Liquid formulations may be aqueous-based or non-aqueous and employed as foams, gels, suspensions, emulsifiable concentrates, or the like. The ingredients may include rheological agents, surfactants, emulsifiers, dispersants, or polymers.

As would be appreciated by a person skilled in the art, the pesticidal concentration will vary widely depending upon the nature of the particular formulation, particularly whether it is a concentrate or to be used directly. The pesticide will be present in at least 1% by weight and may be 100% by weight. The dry formulations will have from about 1-95% by weight of the pesticide while the liquid formulations will generally be from about 1-60% by weight of the solids in the liquid phase. The formulations that contain cells will generally have from about 102 to about 104 cells/mg. These formulations will be administered at about 50 mg (liquid or dry) to 1 kg or more per hectare.

The formulations can be applied to the environment of the pest, e.g., soil and foliage, by spraying, dusting, sprinkling, or the like.

Polynucleotide probes. It is well known that DNA possesses a fundamental property called base complementarity. In nature, DNA ordinarily exists in the form of pairs of anti-parallel strands, the bases on each strand projecting from that strand toward the opposite strand. The base adenine (A) on one strand will always be opposed to the base thymine (T) on the other strand, and the base guanine (G) will be opposed to the base cytosine (C). The bases are held in apposition by their ability to hydrogen bond in this specific way. Though each individual bond is relatively weak, the net effect of many adjacent hydrogen bonded bases, together with base stacking effects, is a stable joining of the two complementary strands. These bonds can be broken by treatments such as high pH or high temperature, and these conditions result in the dissociation, or “denaturation,” of the two strands. If the DNA is then placed in conditions which make hydrogen bonding of the bases thermodynamically favorable, the DNA strands will anneal, or “hybridize,” and reform the original double stranded DNA. If carried out under appropriate conditions, this hybridization can be highly specific. That is, only strands with a high degree of base complementarity will be able to form stable double stranded structures. The relationship of the specificity of hybridization to reaction conditions is well known. Thus, hybridization may be used to test whether two pieces of DNA are complementary in their base sequences. It is this hybridization mechanism which facilitates the use of probes of the subject invention to readily detect and characterize DNA sequences of interest.

The probes may be RNA, DNA, or PNA (peptide nucleic acid). The probe will normally have at least about 10 bases, more usually at least about 17 bases, and may have up to about 100 bases or more. Longer probes can readily be utilized, and such probes can be, for example, several kilobases in length. The probe sequence is designed to be at least substantially complementary to a portion of a gene encoding a toxin of interest. The probe need not have perfect complementarity to the sequence to which it hybridizes. The probes may be labelled utilizing techniques which are well known to those skilled in this art.

One approach for the use of the subject invention as probes entails first identifying by Southern blot analysis of a gene bank of the Bacillus isolate all DNA segments homologous with the disclosed nucleotide sequences. Thus, it is possible, without the aid of biological analysis, to know in advance the probable activity of many new Bacillus isolates, and of the individual gene products expressed by a given Bacillus isolate. Such a probe analysis provides a rapid method for identifying potentially commercially valuable insecticidal toxin genes within the multifarious subspecies of B.t.

One hybridization procedure useful according to the subject invention typically includes the initial steps of isolating the DNA sample of interest and purifying it chemically. Either lysed bacteria or total fractionated nucleic acid isolated from bacteria can be used. Cells can be treated using known techniques to liberate their DNA (and/or RNA). The DNA sample can be cut into pieces with an appropriate restriction enzyme. The pieces can be separated by size through electrophoresis in a gel, usually agarose or acrylamide. The pieces of interest can be transferred to an immobilizing membrane.

The particular hybridization technique is not essential to the subject invention. As improvements are made in hybridization techniques, they can be readily applied.

The probe and sample can then be combined in a hybridization buffer solution and held at an appropriate temperature until annealing occurs. Thereafter, the membrane is washed free of extraneous materials, leaving the sample and bound probe molecules typically detected and quantified by autoradiography and/or liquid scintillation counting. As is well known in the art, if the probe molecule and nucleic acid sample hybridize by forming a strong non-covalent bond between the two molecules, it can be reasonably assumed that the probe and sample are essentially identical. The probe's detectable label provides a means for determining in a known manner whether hybridization has occurred.

In the use of the nucleotide segments as probes, the particular probe is labeled with any suitable label known to those skilled in the art, including radioactive and non-radioactive labels. Typical radioactive labels include

32

P,

35

S, or the like. Non-radioactive labels include, for example, ligands such as biotin or thyroxine, as well as enzymes such as hydrolases or perixodases, or the various chemilurninescers such as luciferin, or fluorescent compounds like fluorescein and its derivatives. The probes may be made inherently fluorescent as described in International Application No. WO 93/16094.

Various degrees of stringency of hybridization can be employed. The more severe the conditions, the greater the complementarity that is required for duplex formation. Severity can be controlled by temperature, probe concentration, probe length, ionic strength, time, and the like. Preferably, hybridization is conducted under moderate to high stringency conditions by techniques well known in the art, as described, for example, in Keller, G. H., M. M. Manak (1987)

DNA Probes

, Stockton Press, New York, N.Y., pp. 169-170.

As used herein “moderate to high stringency” conditions for hybridization refers to conditions which achieve the same, or about the same, degree of specificity of hybridization as the conditions employed by the current applicants. Examples of moderate and high stringency conditions are provided herein. Specifically, hybridization of immobilized DNA on Southern blots with 32P-labeled gene-specific probes was performed by standard methods (Maniatis et al.). In general, hybridization and subsequent washes were carried out under moderate to high stringency conditions that allowed for detection of target sequences with homology to the exemplified toxin genes. For double-stranded DNA gene probes, hybridization was carried out overnight at 20-25° C. below the melting temperature (Tm) of the DNA hybrid in 6×SSPE, 5×Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA. The melting temperature is described by the following formula (Beltz, G. A., K. A. Jacobs, T. H. Eickbush, P. T. Cherbas, and F. C. Kafatos [1983

] Methods of Enzymology

, R. Wu, L. Grossman and K. Moldave [eds.] Academic Press, New York 100:266-285).

Tm=81.5° C.+16.6 Log[Na+]+0.41(%G+C)−0.61(%formamide)−600/length of duplex in base pairs.

Washes are typically carried out as follows:

(1) Twice at room temperature for 15 minutes in 1×SSPE, 0.1% SDS (low stringency wash).

(2) Once at Tm−20° C. for 15 minutes in 0.2×SSPE, 0.1% SDS (moderate stringency wash).

For oligonucleotide probes, hybridization was carried out overnight at 10-20° C. below the melting temperature (Tm) of the hybrid in 6×SSPE, 5×Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA. Tm for oligonucleotide probes was determined by the following formula:

Tm (° C.)=2(number T/A base pairs)+4(number G/C base pairs) (Suggs, S. V., T. Miyake, E. H. Kawashime, M. J. Johnson, K. Itakura, and R. B. Wallace [1981

] ICN

-

UCLA Symp. Dev. Biol. Using Purified Genes

, D. D. Brown [ed.], Academic Press, New York, 23:683-693).

Washes were typically carried out as follows:

(1) Twice at room temperature for 15 minutes 1×SSPE, 0.1% SDS (low stringency wash).

(2) Once at the hybridization temperature for 15 minutes in 1×SSPE, 0.1% SDS (moderate stringency wash).

In general, salt and/or temperature can be altered to change stringency. With a labeled DNA fragment>70 or so bases in length, the following conditions can be used:

Low: 1 or 2×SSPE, room temperature

Low: 1 or 2×SSPE, 42° C.

Moderate: 0.2× or 1×SSPE, 65° C.

High: 0.1×SSPE, 65° C.

Duplex formation and stability depend on substantial complementarity between the two strands of a hybrid, and, as noted above, a certain degree of mismatch can be tolerated. Therefore, the probe sequences of the subject invention include mutations (both single and multiple), deletions, insertions of the described sequences, and combinations thereof, wherein said mutations, insertions and deletions permit formation of stable hybrids with the target polynucleotide of interest. Mutations, insertions, and deletions can be produced in a given polynucleotide sequence in many ways, and these methods are known to an ordinarily skilled artisan. Other methods may become known in the future.

Thus, mutational, insertional, and deletional variants of the disclosed nucleotide sequences can be readily prepared by methods which are well known to those skilled in the art. These variants can be used in the same manner as the exemplified primer sequences so long as the variants have substantial sequence homology with the original sequence. As used herein, substantial sequence homology refers to homology which is sufficient to enable the variant probe to function in the same capacity as the original probe. Preferably, this homology is greater than 50%; more preferably, this homology is greater than 75%; and most preferably, this homology is greater than 90%. The degree of homology needed for the variant to function in its intended capacity will depend upon the intended use of the sequence. It is well within the skill of a person trained in this art to make mutational, insertional, and deletional mutations which are designed to improve the function of the sequence or otherwise provide a methodological advantage.

PCR technology. Polymerase Chain Reaction (PCR) is a repetitive, enzymatic, primed synthesis of a nucleic acid sequence. This procedure is well known and commonly used by those skilled in this art (see Mullis, U.S. Pat. Nos. 4,683,195, 4,683,202, and 4,800,159; Saiki, Randall K., Stephen Scharf, Fred Faloona, Kary B. Mullis, Glenn T. Horn, Henry A. Erlich, Norman Arnheim [1985] “Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia,”

Science

230:1350-1354.). PCR is based on the enzymatic amplification of a DNA fragment of interest that is flanked by two oligonucleotide primers that hybridize to opposite strands of the target sequence. The primers are oriented with the 3′ ends pointing towards each other. Repeated cycles of heat denaturation of the template, annealing of the primers to their complementary sequences, and extension of the annealed primers with a DNA polymerase result in the amplification of the segment defined by the 5′ ends of the PCR primers. Since the extension product of each primer can serve as a template for the other primer, each cycle essentially doubles the amount of DNA fragment produced in the previous cycle. This results in the exponential accumulation of the specific target fragment, up to several million-fold in a few hours. By using a thermostable DNA polymerase such as

Taq

polymerase, which is isolated from the thermophilic bacterium

Thermus aquaticus

, the amplification process can be completely automated. Other enzymes which can be used are known to those skilled in the art.

The DNA sequences of the subject invention can be used as primers for PCR amplification. In performing PCR amplification, a certain degree of mismatch can be tolerated between primer and template. Therefore, mutations, deletions, and insertions (especially additions of nucleotides to the 5′ end) of the exemplified primers fall within the scope of the subject invention. Mutations, insertions and deletions can be produced in a given primer by methods known to an ordinarily skilled artisan.

All of the references cited herein are hereby incorporated by reference.

Following are examples which illustrate procedures for practicing the invention. These examples should not be construed as limiting. All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted.

EXAMPLE 1

Culturing of Bacillus Isolates Useful According to the Invention

The cellular host containing the Bacillus insecticidal gene may be grown in any convenient nutrient medium. These cells may then be harvested in accordance with conventional ways. Alternatively, the cells can be treated prior to harvesting.

The Bacillus cells of the invention can be cultured using standard art media and fermentation techniques. During the fermentation cycle, the bacteria can be harvested by first separating the Bacillus vegetative cells, spores, crystals, and lysed cellular debris from the fermentation broth by means well known in the art. Any Bacillus spores or crystal δ-endotoxins formed can be recovered employing well-known techniques and used as a conventional δ-endotoxin

B.t

. preparation. The supernatant from the fermentation process contains toxins of the present invention. The toxins are isolated and purified employing well-known techniques.

A subculture of Bacillus isolates, or mutants thereof, can be used to inoculate the following medium, known as TB broth:

Tryptone

12

g/l

Yeast Extract

24

g/l

Glycerol

4

g/l

KH

2

PO

4

2.1

g/l

K

2

HPO

4

14.7

g/l

pH

7.4

The potassium phosphate was added to the autoclaved broth after cooling. Flasks were incubated at 30° C. on a rotary shaker at 250 rpm for 24-36 hours.

The above procedure can be readily scaled up to large fermentors by procedures well known in the art.

The Bacillus obtained in the above fermentation, can be isolated by procedures well known in the art. A frequently-used procedure is to subject the harvested fermentation broth to separation techniques, e.g., centrifugation. In a specific embodiment, Bacillus proteins useful according the present invention can be obtained from the supernatant. The culture supernatant containing the active protein(s) can be used in bioassays.

Alternatively, a subculture of Bacillus isolates, or mutants thereof, can be used to inoculate the following peptone, glucose, salts medium:

Bacto Peptone

7.5

g/l

Glucose

1.0

g/l

KH

2

PO

4

3.4

g/l

K

2

HPO

4

4.35

g/l

Salt Solution

5.0

ml/l

CaCl

2

Solution

5.0

ml/l

pH

7.2

Salts Solution (100 ml)

MgSO

4

.7H

2

O

2.46

g

MnSO

4

.H

2

O

0.04

g

ZnSO

4

.7H

2

O

0.28

g

FeSO

4

.7H

2

O

0.40

g

CaCl

2

Solution (100 ml)

CaCl

2

.2H

2

O

3.66

g

The salts solution and CaCl

2

solution are filter-sterilized and added to the autoclaved and cooked broth at the time of inoculation. Flasks are incubated at 30° C. on a rotary shaker at 200 rpm for 64 hr.

The above procedure can be readily scaled up to large fermentors by procedures well known in the art.

The Bacillus spores and/or crystals, obtained in the above fermentation, can be isolated by procedures well known in the art. A frequently-used procedure is to subject the harvested fermentation broth to separation techniques, e.g., centrifugation.

EXAMPLE 2

Isolation and Preparation of Cellular DNA for PCR

DNA can be prepared from cells grown on Spizizen's agar, or other minimal or enriched agar known to those skilled in the art, for approximately 16 hours. Spizizen's casamino acid agar comprises 23.2 g/l Spizizen's minimal salts [(NH

4

)

2

SO

4

, 120 g; K

2

HPO

4

, 840 g; KH

2

PO

4

, 360 g; sodium citrate, 60 g; MgSO

4

. 7H

2

O, 12 g. Total: 1392 g]; 1.0 g/l vitamin-free casamino acids; 15.0 g/l Difco agar. In preparing the agar, the mixture was autoclaved for 30 minutes, then a sterile, 50% glucose solution can be added to a final concentration of 0.5% (1/100 vol). Once the cells are grown for about 16 hours, an approximately 1 cm

2

patch of cells can be scraped from the agar into 300 μl of 10 mM Tris-HCl (pH 8.0)−1 mM EDTA. Proteinase K was added to 50 μg/ml and incubated at 55° C. for 15 minutes. Other suitable proteases lacking nuclease activity can be used. The samples were then placed in a boiling water bath for 15 minutes to inactivate the proteinase and denature the DNA. This also precipitates unwanted components. The samples are then centrifuged at 14,000×g in an Eppendorf microfuge at room temperature for 5 minutes to remove cellular debris. The supernatants containing crude DNA were transferred to fresh tubes and frozen at −20° C. until used in PCR reactions.

Alternatively, total cellular DNA may be prepared from plate-grown cells using the QIAamp Tissue Kit from Qiagen (Santa Clarita, Calif.) following instructions from the manufacturer.

EXAMPLE 3

Primers Useful for Characterizing and/or Identifying Toxin Genes

The following set of PCR primers can be used to identify and/or characterize genes of the subject invention, which encode pesticidal toxins:

GGRTTAMTTGGRTAYTATTT (SEQ ID NO. 3)

ATATCKWAYATTKGCATTTA (SEQ ID NO. 4)

Redundant nucleotide codes used throughout the subject disclosure are in accordance with the IUPAC convention and include:

R=A or G

M=A or C

Y=C or T

K=G or T

W=A or T

EXAMPLE 4

Identification and Sequencing of Genes Encoding Novel Soluble Protein Toxins From Bacillus Strains

PCR using primers SEQ ID NO. 3 and SEQ ID NO. 4 was performed on total cellular genomic DNA isolated from a broad range of

B.t

. strains. Those samples yielding an approximately 1 kb band were selected for characterization by DNA sequencing. Amplified DNA fragments were first cloned into the PCR DNA TA-cloning plasmid vector, pCR2.1, as described by the supplier (Invitrogen, San Diego, Calif.). Plasmids were isolated from recombinant clones and tested for the presence of an approximately 1 kbp insert by PCR using the plasmid vector primers, T3 and T7.

The following strains yielded the expected band of approximately 1000 bp, thus indicating the presence of a MIS-type toxin gene: PS66D3, PS177C8, PS177I8, PS33F1, PS157C1 (157C1-A), PS201Z, PS31F2, and PS185Y2.

Plasmids were then isolated for use as sequencing templates using QIAGEN (Santa Clarita, Calif.) miniprep kits as described by the supplier. Sequencing reactions were performed using the Dye Terminator Cycle Sequencing Ready Reaction Kit from PE Applied Biosystems. Sequencing reactions were run on a ABI PRISM 377 Automated Sequencer. Sequence data was collected, edited, and assembled using the ABI PRISM 377 Collection, Factura, and AutoAssembler software from PE ABI. DNA sequences were determined for portions of novel toxin genes from the following isolates: PS66D3, PS177C8, PS177I8, PS33F1, PS157C1 (157C1-A), PS201Z, PS31F2, and PS185Y2. These nucleotide sequences are shown in SEQ ID NOS. 5, 7, 9, 38, 33, 35, 36, and 37, respectively. Polypeptide sequences were deduced for portions of the encoded, novel soluble toxins from the following isolates: PS66D3, PS177C8, PS177I8, and PS157C1 (toxin 157C1-A). These nucleotide sequences are shown in SEQ ID NOS. 6, 8, 10, and 34, respectively.

EXAMPLE 5

Restriction Fragment Length Polymorphism (RFLP) of Toxins From

Bacillus thuringiensis

Strains

Total cellular DNA was prepared from various

Bacillus thuriengensis

(

B.t

.) strains grown to an optical density of 0.5-0.8 at 600 nm visible light. DNA was extracted using the Qiagen Genomic-tip 500/G kit and Genomic DNA Buffer Set according to protocol for Gram positive bacteria (Qiagen Inc.; Valencia, Calif.).

Standard Southern hybridizations using

32

P-lableled probes were used to identifiy and characterize novel toxin genes within the total genomic DNA preparations. Prepared total genomic DNA was digested with various restriction enzymes, electrophoresed on a 1% agarose gel, and immobilized on a supported nylon membrane using standard methods (Maniatis et al.).

PCR-amplified DNA fragments 1.0-1.1 kb in length were gel purified for use as probes. Approximately 25 ng of each DNA fragment was used as a template for priming nascent DNA synthesis using DNA polymerase I Klenow fragment (New England Biolabs), random hexanucleotide primers (Boehringer Mannheim) and

32

PdCTP.

Each

32

P-lableled fragment served as a specific probe to its corresponding genomic DNA blot. Hybridizations of immobilized DNA with randomly labeled

32

P probes were performed in standard aqueous buffer consisting of 5×SSPE, 5×Denhardt's solution, 0.5% SDS, 0.1 mg/ml at 65° C. overnight. Blots were washed under moderate stringency in 0.2×SSC, 0.1% SDS at 65° C. and exposed to film. RFLP data showing specific hybridization bands containing all or part of the novel gene of interest was obtained for each strain.

TABLE 3

(Strain)/

Probe Seq

Gene Name

I.D. Number

RFLP Data (approximate band sizes)

(PS)66D3

24

BamHI: 4.5 kbp, HindIII: >23 kbp, KpnI: 23

kbp, PstI: 15 kbp, XbaI: >23 kbp

(PS)177I8

33

BamHI: >23 kbp, EcoRI: 10 kbp, HindIII: 2

kbp, SalI: >23 kbp, XabI: 3.5 kbp

In separate experiments, alternative probes for MIS and WAR genes were used to detect novel toxin genes on Southern blots of genomic DNA by

32

P autoradiography or by non-radioactive methods using the DIG nucleic acid labeling and detection system (Boehringer Mannheim; Indianapolis, Ind.). DNA fragments approximately 2.6 kbp (PS177C8 MIS toxin gene; SEQ ID NO. 7) and 1.3 kbp (PS177C8 WAR toxin gene; SEQ ID NO. 11) in length were PCR amplified from plasmid pMYC2450 using primers homologous to the 5′ and 3′ ends of each respective gene. pMYC2450 is a recombinant plasmid containing the PS177C8 MIS and WAR genes on an approximately 14 kbp ClaI fragment in pHTBlueII (an

E. coli/B. thuringiensis

shuttle vector comprised of pBluescript S/K [Stratagene, La Jolla, Calif.] and the replication origin from a resident

B.t

. plasmed [D. Lereclus et al. 1989; FEMS Microbiology Letters 60:211-218]). These DNA fragments were used as probes for MIS RFLP classes A through N and WAR RFLP classes A through L. RFLP data in Table 4 for class O was generated using MIS fragments approximately 1636 bp amplified with primers S1-633F (CACTCAAAAAATGAAAAGGGAAA; SEQ ID NO. 39) and S1-2269R (CCGGTTTTATTGATGCTAC; SEQ ID NO. 40). RFLP data in Table 5 for class M was generated using WAR fragments approximately 495 bp amplified with primers S2-501F (AGAACAATTTTTAGATAGGG; SEQ ID NO. 41) and S2-995R (TCCCTAAAGCATCAGAAATA; SEQ ID NO 42).

Fragments were gel purified and approximately 25 ng of each DNA fragment was randomly labeled with

32

P for radioactive detection or approximately 300 ng of each DNA fragment was randomly labeled with the DIG High Prime kit for nonradioactive detection. Hybridization of immobilized DNA with randomly labeled

32

P probes were performed in standard formamide conditions: 50% formamide, 5×SSPE, 5×Denhardt's solution, 2% SDS, 0.1 mg/ml sonicated sperm DNA at 42° C. overnight. Blots were washed under low stringency in 2×SSC, 0.1% SDS at 42° C. and exposed to film. RFLP data showing DNA bands containing all or part of the novel gene of interest was obtained for each strain.

RFLP data using MIS probes as discussed above were as follows:

TABLE 4

RFLP

RFLP Data (approximate band

Class

Strain Name(s)

size in base pairs)

A

177C8, 74H3, 66D3

HindIII: 2,454; 1,645

XbaI: 14,820; 9,612; 8,138;

5,642; 1,440

B

177I8

HindIII: 2,454

XbaI: 3,500 (very faint 7,000)

C

66D3

HindIII: 2,454 (faint 20,000)

XbaI: 3,500 (faint 7,000)

D

28M, 31F2, 71G5,

HindIII: 11,738; 7,614

71G7, 71I1, 71N1,

XbaI: 10,622; 6,030

146F, 185Y2, 201JJ7,

KB73, KB68B46-2,

KB71A35-4,

KB71A116-1

D

1

70B2, 71C2

HindIII: 11,738; 8,698; 7,614

XbaI: 11,354; 10,622; 6,030

E

KB68B51-2, KB68B55-

HindIII: 6,975; 2,527

2

XbaI: 10,000; 6,144

F

KB53A49-4

HindIII: 5,766

XbaI: 6,757

G

86D1

HindIII: 4,920

XbaI: 11,961

H

HD573B, 33F1, 67B3

HindIII: 6,558; 1,978

XbaI: 7,815; 6,558

I

205C, 40C1

HindIII: 6,752

XbaI: 4,618

J

130A3, 143A2, 157C1

HindIII: 9,639; 3,943, 1,954; 1,210

XbaI: 7,005; 6,165; 4,480; 3,699

K

201Z

HindIII: 9,639; 4,339

XbaI: 7,232; 6,365

L

71G4

HindIII: 7,005

XbaI: 9.639

M

KB42A33-8, KB71A72-

HindIII: 3,721

1, KB71A133-11

XbaI: 3,274

N

KB71A134-2

HindIII: 7,523

XbaI: 10,360; 3,490

O

KB69A125-3,

HindIII: 6,360; 3,726; 1,874; 1,098

KB69A127-7,

XbaI: 6,360; 5,893; 5,058; 3,726

KB69A136-2,

KB7120-4

RFLP data using WAR probes as discussed above were as follows:

TABLE 5

RFLP

RFLP Data (approximate band

Class

Strain Name(s)

size in base pairs)

A

177C8, 74H3

HindIII: 3,659, 2,454, 606

XbaI: 5,457, 4,469, 1,440, 966

B

177I8, 66D3

data unavailable

C

28M, 31F2, 71G5, 71G7, 71I1,

HindIII: 7,614

71N1, 146F, 185Y2, 201JJ7,

XbaI: 10,982, 6,235

KB73, KB68B46-2, KB71A35-

4, KB71A116-1

C1

70B2, 71C2

HindIII: 8,698, 7,614

XbaI: 11,354, 6,235

D

KB68B51-2, KB68B55-2

HindIII: 7,200

Xbal: 6,342 (and 11,225 for 51-

2)(and 9,888 for 55-2)

E

KB53A49-4

HindIII: 5,766

XbaI: 6,757

F

HD573B, 33F1, 67B3

HindIII: 3,348, 2,037 (and

6,558 for

HD573B only)

XbaI: 6,953 (and 7,815,

6,185 for

HD573B only)

G

205C, 40C1

HindIII: 3,158

XbaI: 6,558, 2,809

H

130A3, 143A2, 157C1

HindIII: 4,339, 3,361, 1,954,

660, 349

XbaI: 9.043, 4,203, 3,583,

2,958, 581, 464

I

201Z

HindIII: 4,480, 3,819, 703

XbaI: 9,336, 3,256, 495

J

71G4

HindIII: 7,005

XbaI: 9,639

K

KB42A33-8, KB71A72-1,

no hybridization signal

KB71A133-l1

L

KB71A134-2

HindIII: 7,523

XbaI: 10,360

M

KB69A125-3, KB69A127-7,

HindIII: 5,058; 3,726;

KB69A136-2,

3,198; 2,745;

KB71A20-4

257

XbaI: 5,255; 4,341;

3,452; 1,490; 474

EXAMPLE 6

Characterization and/or Identification of WAR Toxins

In a further embodiment of the subject invention, pesticidal toxins can be characterized and/or identified by their level of reactivity with antibodies to pesticidal toxins exemplified herein. In a specific embodiment, antibodies can be raised to WAR toxins such as the toxin obtainable from PS177C8a. Other WAR toxins can then be identified and/or characterized by their reactivity with the antibodies. In a preferred embodiment, the antibodies are polyclonal antibodies. In this example, toxins with the greatest similarity to the 177C8a-WAR toxin would have the greatest reactivity with the polyclonal antibodies. WAR toxins with greater diversity react with the 177C8a polyclonal antibodies, but to a lesser extent. Toxins which immunoreact with polyclonal antibodies raised to the 177C8a WAR toxin can be obtained from, for example, the isolates designated PS177C8a, PS177I8, PS66D3, KB68B55-2, PS185Y2, KB53A49-4, KB68B51-2, PS31F2, PS74H3, PS28M, PS71G6, PS71G7, PS71I1, PS71N1, PS201JJ7, KB73, KB68B46-2, KB71A35-4, KB71A116-1, PS70B2, PS71C2, PS86D1, HD573B, PS33F1, PS67B3, PS205C, PS40C1, PS130A3, PS143A2, PS157C1, PS201Z, PS71G4, KB42A33-8, KB71A72-1, KB71A133-11, KB71A134-2, KB69A125-3, KB69A127-7, KB69A136-2, and KB71A20-4. Isolates PS31F2 and KB68B46-2 show very weak antibody reactivity, suggesting advantageous diversity.

EXAMPLE 7

Molecular Cloning and DNA Sequence Analysis of Soluble Insecticidal Protein (MIS and WAR) Genes From

Bacillus thuringiensis

Strain PS205C

Total cellular DNA was prepared from

Bacillus thuringensis

strain PS205C grown to an optical density of 0.5-0.8 at 600 nm visible light in Luria Bertani (LB) broth. DNA was extracted using the Qiagen Genomic-tip 500/G kit and Genomic DNA Buffer Set according to the protocol for Gram positive bacteria (Qiagen Inc.; Valencia, Calif.). A PS205C cosmid library was constructed in the SuperCos vector (Stratragene) using inserts of PS205C total cellular DNA partially digested with Nde II. XL1-Blue cells (Stratagene) were transfected with packaged cosmids to obtain clones resistant to carbenicillin and kanamycin. 576 cosmid colonies were grown in 96-well blocks in 1 ml LB+carbenicillin (100 μg/ml)+kanamycin (50 μg/ml) at 37° C. for 18 hours and replica plated onto nylon filters for screening by hybridization.

A PCR amplicon containing approximately 1000 bp of the PS205C MIS gene was amplified from PS205 genomic DNA using primers SEQ ID NO. 3 and SEQ ID NO. 4 as described in Example 4. The DNA fragment was gel purified using QiaexII extraction (Qiagen). The probe was radiolabeled with

32

P-dCTP using the Prime-It II kit (Stratgene) and used in aqueous hybridization solution (6×SSPE, 5×Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA) with the colony lift filters at 65° C. for 16 hours. The colony lift filters were briefly washed 1× in 2×SSC/0. 1% SDS at room temperature followed by two additional washes for 10 minutes in 0.5×SSC/0.1% SDS. The filters were then exposed to X-ray film for 5.5 hours. One cosmid clone that hybridized strongly to the probe was selected for further analysis. This cosmid clone was confirmed to contain the MIS gene by PCR amplification with primers SEQ ID NO. 3 and SEQ ID NO. 4. This cosmid clone was designated as pMYC3105; recombinant

E. coli

XL-1Blue MR cells containing pMYC3105 are designated MR992.

A subculture of MR992 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on May 4, 1999. The accession number is NRRL B-30124. A truncated plasmid clone for PS205C was also deposited on May 4, 1999. The accession number is NRRL B-30122.

To sequence the PS205C MIS and WAR genes, random transposon insertions into pMYC3105 were generated using the GPS-1 Genome Priming System and protocols (New England Biolabs). The GPS2 trasposition vector encoding chloramphenicol resistance was chosen for selection of cosmids containing insertions. pMYC3105 cosmids that acquired transposons were identified by transformation and selection of

E. coli

XL1-Blue MR on media containing ampicillin, kanamycin and chloramphenicol. Cosmid templates were prepared from individual colonies for use as sequencing templates using the Multiscreen 96-well plasmid prep (Millipore). The MIS and WAR toxin genes encoded by pMYC3105 were sequenced with GPS2 primers using the ABI377 automated sequencing system and associated software. The MIS and WAR genes were found to be located next to one another in an apparent transcriptional operon. The nucleotide and deduced polypeptide sequences are designated as new SEQ ID NOS. 43-46.

EXAMPLE 8

Molecular Cloning and DNA Sequence Analysis of Soluble Insecticidal Protein (MIS and WAR) Genes From

Bacillus Thuringensis Strain PS

31F2

a. Preparation and Cloning of Genomic DNA

Total cellular DNA was prepared from the

Bacillus thuringensis

strain PS31F2 grown to an optical density of 0.5-0.8 at 600 nm visible light in Luria Bertani (LB) broth. DNA was extracted using the Qiagen Genomic-tip 500/G kit or Genomic-Tip 20/G and Genomic DNA Buffer Set (Qiagen Inc.; Valencia, Calif.) according to the protocol for Gram positive bacteria.

Lambda libraries containing total genomic DNA from

Bacillus thuringensis

strain PS31F2 were prepared from DNA partially digested with NdeII. Partial NdeII restriction digests were electrophoresed on a 0.7% agarose gel and the region of the gel containing DNA fragments within the size range of 9-20 kbp was excised from the gel. DNA was electroeluted from the gel fragment in 0.1×TAE buffer at approximately 30 V for one hour and purified using Elutip-d columns (Schleicher and Schuell; Keene, N.H.).

Purified, fractionated DNA was ligated into BamHI-digested Lambda-GEM-11 arms (Promega Corp., Madison, Wis.). Ligated DNA was then packaged into lambda phage using Gigapack III Gold packaging extract (Stratagene Corp., La Jolla, Calif.).

E. coli

strain KW251 was infected with recombinant phage and plated onto LB plates in LB top agarose. Plaques were lifted onto nitrocellulose filters and prepared for hybridization using standard methods (Maniatis, et al.). DNA fragments approximately 1.1 kb (PS177C8 MIS) or 700 bp (PS177C8 WAR) in length were PCR amplified from plasmid pMYC2450 and used as the probes. Fragments were gel purified and approximately 25 ng of each DNA fragment was randomly labeled with

32

P-dCTP. Hybridization of immobilized DNA with randomly

32

P-labeled PS177C8 probes was performed in standard formamide conditions: 50% formamide, 5×SSPE, 5×Denhardt's solution, 2% SDS, 0.1 mg/ml at 42° C. overnight. Blots were washed under low stringency in 2×SSC, 0.1% SDS at 42° C. and exposed to film. Hybridizing plaques were isolated from the plates and suspended in SM buffer. Phage DNA was prepared using LambdaSorb phage adsorbent (Promega, Madison, Wis.). PCR using the oligonucleotide primers SEQ ID NO. 3 and SEQ ID NO. 4 was performed using phage DNA templates to verify the presence of the target gene. The PCR reactions yielded the expected 1 kb band in both DNA samples confirming that those phage clones contain the gene of interest. For subcloning, phage DNA was digested with various enzymes, fractionated on a 1% agarose gel and blotted for Southern analysis. Southern analysis was performed as decribed above. A HindIII fragment approximately 8 kb in size was identified that contained the PS31F2 toxin genes. This fragment was gel purified and cloned into the HindIII site of pBluescriptII (SK+); this plasmid clone is designated pMYC2610. The recombinant

E. coli

XL10Gold [pMYC2610] strain was designated MR983.

A subculture of MR983 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on May 4, 1999. The accession number is NRRL B-30123.

b. DNA Sequencing

The pMYC2610 HindIII fragment containing the PS31F2 toxin genes was isolated by restriction digestion, fractionation on a 0.7% agarose gel and purification from the gel matrix using the QiaexII kit (Qiagen Inc.; Valencia, Calif.). Gel purified insert DNA was then digested separately with restriction enzymes AluI, MseI, or RsaI and fractionated on a 1% agarose gel. DNA fragments between 0.5 and 1.5 kb were excised from the gel and purified using the QiaexII kit. Recovered fragments were ligated into EcoRV digested pBluescriptII and transformed into

E. coli

XL10 Gold cells. Plasmid DNA was prepared from randomly chosen transformants, digested with NotI and ApaI to verify insert size and used as sequencing templates with primers homologous to plasmid vector sequences. Primer walking was used to complete the sequence. Sequencing reactions were performed using dRhodamine or BigDye Sequencing kit (ABI Prism/Perkin Elmer Applied Biosystems) and run on ABI 373 or 377 automated sequencers. Data was analyzed using Factura, Autoassembler (ABI Prism) and Gentics Computer Group (Madison, Wis.) programs. The MIS and WAR genes were found to be located next to one another in an apparent transcriptional operon. The WAR gene is 5′ to the MIS gene, and the two genes are separated by 4 nucleotide bases.

The nucleotide sequences and deduced peptide sequences for the novel MIS and WAR genes from PS31F2 are reported as new SEQ ID NOS. 47-50.

c. Subcloning and Transformation of

B. thuringiensis

The PS31F2 toxin genes were subcloned on the 8 kbp HinDIII fragment from pMYC2610 into the

E. coli/B.t

. shuttle vector, pHT370 (O. Arantes and D. Lereclus. 1991. Gene 108: 115-119), for expression from the native

Bacillus

promoter. The resulting plasmid construct was designated pMYC2615. pMYC2415 plasmid DNA was prepared from recombinant

E.coli

XL10Gold for transformation into the acrystallierous (Cry-)

B.t

. host, CryB (A. Aronson, Purdue University, West Lafayette, Ind.), by electroporation. The recombinant CryB [pMYC2615] strain was designated MR558.

EXAMPLE 9

Molecular Cloning and DNA Sequence Analysis of a Novel SUP Toxin Gene From

Bacillus Thuringiensis

strain KB59A4-6

Total cellular DNA was prepared from the

Bacillus thuringensis

strain KB59A4-6 grown to an optical density of 0.5-0.8 at 600 nm visible light in Luria Bertani (LB) broth. DNA was extracted using the Qiagen Genomic-tip 500/G kit and Genomic DNA Buffer Set according to the protocol for Gram positive bacteria (Qiagen Inc.; Valencia, Calif.). DNA was digested with HinDIII and run on 0.7% agarose gels for Southern blot analysis by standard methods (Maniatis et al.). A PCR amplicon containing the SUP-like gene (SEQ ID NO. 1) from Javelin-90 genomic DNA was obtained by using the oligos “3A-atg (GCTCTAGAAGGAGGTAACTTATGAACAAGAATAATACTAAATTAAGC) (SEQ ID NO. 51) and “3A-taa” (GGGGTACCTTACTTAATAGAGACATCG) (SEQ ID NO. 52). This DNA fragment was gel purified and labeled with radioactive

32

P-dCTP using Prime-It II Random Primer Labeling Kit (Stratagene) for use as a probe. Hybridization of Southern blot filters was carried out in a solution of 6×SSPE, 5×Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA at 42° C. overnight in a shaking water bath. The filters were subsequently washed in 1×SSPE and 0.1% SDS once at 25° C. followed by two additional washes at 37° C. Hybridized filters were then exposed to X-ray film at −80° C. An approximately 1 kbp HinDIII fragment of KB59A4-6 genomic DNA was identified that hybridized to the Javelin 90 SUP probe.

A lambda library of KB59A4-6 genomic DNA was constructed as follows. DNA was partially digested with Sau3A and size-fractionated on agarose gels. The region of the gel containing fragments between 9.0 and 23 kbp was excised and DNA was isolated by electroelution in 0.1×TAE buffer followed by purification over Elutip-d columns (Schleicher and Schuell, Keene, N.H.). Size-fractionated DNA inserts were ligated into BamHI-digested Lambda-Gem 11 (Promega) and recombinant phage were packaged using GigapackIII XL Packing Extract (Stratagene). Phage were plated on

E. coli

VCS257 cells for screening by hybridization. Plaques were transferred to nylon filters and dried under vacuum at 80° C. Hybridization was then performed with the Javelin 90 Sup gene probe as described above. One plaque that gave a positive signal was selected using a Pasteur pipette to obtain a plug. The plug was soaked over-night at room temperature in 1 mL SM buffer+10 uL CHCl

3

. Large-scale phage DNA preparations (Maniatis et al.) were obtained from liquid lysates of

E. coli

KW251 infected with this phage.

The KB59A4-6 toxin gene was subcloned into the

E. coli/B. thuringiensis

shuttle vector, pHT370 (O. Arantes and D. Lereclus. 1991. Gene 108: 115-119), on an approximately 5.5 kbp SacI/XbaI fragment identified by Southern hybridization. This plasmid subclone was designated pMYC2473. Recombinant

E. coli

XL10-Gold cells (Stratagene) containing this construct are designated MR993. The insecticidal toxin gene was sequenced by primer walking using pMYC2473 plasmid and PCR amplicons as DNA templates. Sequencing reactions were performed using the Dye Terminator Cycle Sequencing Ready Reaction Kit from PE Applied Biosystems and run on a ABI PRISM 377 Automated Sequencer. Sequence data was analyzed using the PE ABI PRISM 377 Collection, Factura, and AutoAssembler software. The DNA sequence and deduced peptide sequence of the KB59A4-6 toxin are reported as new SEQ ID NOS. 53 and 54, respectively.

A subculture of MR993 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on May 4, 1999. The accession number is NRRL B-30125.

EXAMPLE 10

Bioassays for Activity Against Lepidopterans and Coleopterans

Biological activity of the toxins and isolates of the subject invention can be confirmed using standard bioassay procedures. One such assay is the budworm-bollworm (

Heliothis virescens

[Fabricius] and

Helicoverpa zea

[Boddie]) assay. Lepidoptera bioassays were conducted with either surface application to artificial insect diet or diet incorporation of samples. All Lepidopteran insects were tested from the neonate stage to the second instar. All assays were conducted with either toasted soy flour artificial diet or black cutworm artificial diet (BioServ, Frenchtown, N.J.).

Diet incorporation can be conducted by mixing the samples with artificial diet at a rate of 6 mL suspension plus 54 mL diet. After vortexing, this mixture is poured into plastic trays with compartmentalized 3-ml wells (Nutrend Container Corporation, Jacksonville, Fla.). A water blank containing no

B.t

. serves as the control. First instar larvae (USDA-ARS, Stoneville, Miss.) are placed onto the diet mixture. Wells are then sealed with Mylar sheeting (ClearLam Packaging, Ill.) using a tacking iron, and several pinholes are made in each well to provide gas exchange. Larvae were held at 25° C. for 6 days in a 14:10 (light:dark) holding room. Mortality and stunting are recorded after six days.

Bioassay by the top load method utilizes the same sample and diet preparations as listed above. The samples are applied to the surface of the insect diet. In a specific embodiment, surface area ranged from 0.3 to approximately 0.8 cm

2

depending on the tray size, 96 well tissue culture plates were used in addition to the format listed above. Following application, samples are allowed to air dry before insect infestation. A water blank containing no

B.t

. can serve as the control. Eggs are applied to each treated well and were then sealed with Mylar sheeting (ClearLam Packaging, Ill.) using a tacking iron, and pinholes are made in each well to provide gas exchange. Bioassays are held at 25° C. for 7 days in a 14:10 (light:dark) or 28° C. for 4 days in a 14:10 (light:dark) holding room. Mortality and insect stunting are recorded at the end of each bioassay.

Another assay useful according to the subject invention is the Western corn rootworm assay. Samples can be bioassayed against neonate western corn rootworm larvae (

Diabrotica virgifera virgifera

) via top-loading of sample onto an agar-based artificial diet at a rate of 160 ml/cm

2

. Artificial diet can be dispensed into 0.78 cm

2

wells in 48-well tissue culture or similar plates and allowed to harden. After the diet solidifies, samples are dispensed by pipette onto the diet surface. Excess liquid is then evaporated from the surface prior to transferring approximately three neonate larvae per well onto the diet surface by camel's hair brush. To prevent insect escape while allowing gas exchange, wells are heat-sealed with 2-mil punched polyester film with 27HT adhesive (Oliver Products Company, Grand Rapids, Mich.). Bioassays are held in darkness at 25° C., and mortality scored after four days.

Analogous bioassays can be performed by those skilled in the art to assess activity against other pests, such as the black cutworm (

Agrotis ipsilon

).

Results are shown in Table 6.

TABLE 6

Genetics and function of concentrated B.t. supernatants screened for lepidopteran and coleopteran activity

Approx.

ca. 80-100

339 bp PCR

Total Protein

kDa protein

H. virescens

H. zen

Diabrotica

Strain

fragment

(μg/cm

2

)

(μg/cm

2

)

% mortality

Stunting

% mortality

Stunting

% mortality

PS157C1 (#1)

—

24

2

43

yes

13

yes

—

PS157C1 (#2)

—

93

8

—

—

−

—

40

PS157C1 (#3)

—

35

3

−

—

—

—

18

Javelin 1990

++

43.2

3.6

100

yes

96

yes

NT

water

0-8

—

0-4

-

12

EXAMPLE 11

Results of Western Corn Rootworm Bioassays and Further Characterization of the Toxins

Concentrated liquid supernatant solutions, obtained according to the subject invention, were tested for activity against Western corn rootworm (WCRW). Supernatants from the following isolates were found to cause mortality against WCRW: PS31F2, PS66D3, PS177I8, KB53A49-4, KB68B46-2, KB68B51-2, KB68B55-2, and PS177C8.

Supernatants from the following isolates were also found to cause mortality against WCRW: PS205A3, PS185V2, PS234E1, PS71G4, PS248N10, PS191A21, KB63B19-13, KB63B19-7, KB68B62-7, KB68B63-2, KB69A125-1, KB69A125-3, KB69A125-5, KB69A127-7, KB69A132-1, KB69B2-1, KB70B5-3, KB71A125-15, and KB71A35-6; it was confirmed that this activity was heat labile. Furthermore, it was determined that the supernatants of the following isolates did not react (yielded negative test results) with the WAR antibody (see Example 12), and did not react with the MIS (SEQ ID NO. 31) and WAR (SEQ ID NO. 51) probes: PS205A3, PS185V2, PS234E1, PS71G4, PS248N10, PS191A21, KB63B19-13, KB63B19-7, KB68B62-7, KB68B63-2, KB69A125-1, KB69A125-5, KB69A132-1, KB69B2-1, KB70B5-3, KB71A125-15, and KB71A35-6; the supernatants of isolates KB69A125-3 and KB69A127-7 yielded positive test results.

EXAMPLE 12

Culturing of 31F2 Clones and Bioassay of 31F2 Toxins on Western Corn Rootworm (wCRW)

E. coli

MR983 and the negative control strain MR948 (

E. coli

XL1-Blue [pSupercos]; vector control) were grown in 250 ml bottom baffled flasks containing 50 ml of DIFCO Terrific Broth medium. Cultures were incubated in New Brunswick shaker agitating at 250 RPM, 30° C. for ˜23 hours. After 23 hours of incubation samples were aseptically taken to examine the cultures under the microscope to check for presence of contaminants. 30 ml of culture were dispensed into a 50 ml centrifuge tube and centrifuged in a Sorvall centrifuge at 15,000 rpm for 20 minutes. The 1× supernatant was saved and submitted for bioassay against wCRW. The pellet was resuspended 5× with 10 mM TRIS buffer, and was sonicated prior to submission for bioassay against wCRW.

B.t

. strain MR558 and the negative control MR539 (

B.t

. cry B[pHT Blue II]; vector control) were grown in the same manner except for the omission of glycerol from the Terrific Broth medium.

B.t

. cell pellets were resuspended in water rather than buffer prior to sonication.

Assays for the

E. coli

clone MR983 and

B. thuringiensis

clone MR558 containing the 31F2 toxin genes were conducted using the same experimental design as in Example 10 for western corn rootworm with the following exceptions: Supernatant samples were top-loaded onto diet at a dose of ˜160 ul/cm

2

. B.t

. cellular pellet samples at a 5× concentration were top-loaded onto the diet at a dose of˜150 ul/ cm

2

for both clones, and at ˜75, and at doses of ˜35 ul/ cm2 for the MR558

B. thuringiensis

clone (quantity of active toxin unknown for either clone). Approximately 6-8 larvae were transferred onto the diet immediately after the sample had evaporated. The bioassay plate was sealed with mylar sheeting using a tacking iron and pinholes were made above each well to provide gas exchange. Both the MR983 and MR558 clones demonstrated degrees of bioactivity (greater mortality) against western corn rootworm as compared to the toxin-negative clones MR948 and MR539.

Table 7 presents the results showing the bioactivity of cloned PS31F2 toxins against western corn rootworm.

TABLE 7

Percent Mortality of wCRW

Toxin

Rate

Supernatant

Pellet 5X

Pellet 5X

Pellet 5X

Strain

genes

=>

160 ul/cm

2

150 ul/cm

2

75 ul/cm

2

35 ul/cm

2

MR983

31F2

7%

19%

—

—

(4/56)

(5/27)

MR948

none

4%

26%

—

—

(1/24)

(6/23)

MR983

31F2

3%(5/147)

—

20%

—

(49/245)

MR948

none

27%(19/70)

—

51%

—

(79/154)

MR983

31F2

13%(32/243)

—

33%

—

(85/259)

MR948

none

9%(14/155)

—

20%

—

(55/273)

MR558

31F2

35%(41/118)

88%

9%(9/100)

13%(13/97)

(43/49)

MR539

none

10%(14/134)

14%

15%

17%(19/111)

(3/21)

(17/11)

MR558

31F2

3%(1/29)

35%(17/

29%(15/52)

13%(7/55)

48)

MR539

none

19%(5/27)

20%(9/

31%(18/

18%(9/49)

46)

57)

MR558

31F2

13%(9/69)

38%(19/

18%(15/

15%(10/65)

50)

85)

MR539

none

29%(16/55)

24%(14/

14%(13/

28%(18/64)

58)

91)

MR558

31F2

7%(5/74)

14%

17%(14/83)

11%(6/57)

(9/66)

MR539

none

11%(9/79)

32%

9%(7/78)

15%(10/67)

(19/59)

EXAMPLE 13

Target Pests

Toxins of the subject invention can be used, alone or in combination with other toxins, to control one or more non-mammalian pests. These pests may be, for example, those listed in Table 8. Activity can readily be confirmed using the bioassays provided herein, adaptations of these bioassays, and/or other bioassays well known to those skilled in the art.

TABLE 8

Target pest species

ORDER/Common Name

Latin Name

LEPIDOPTERA

European Corn Borer

Ostrinia nubilalis

European Corn Borer resistant to

Ostrinia nubilalis

Cry1A-class of toxins

Black Cutworm

Agrotis ipsilon

Fall Armyworm

Spodoptera frugiperda

Southwestern Corn Borer

Diatraea grandioseila

Corn Earworm/Bollworm

Helicoverpa zea

Tobacco Budworm

Heliothis virescens

Tobacco Budworm resistant to

Heliothis virescens

Cry1A-class of toxins

Sunflower Head Moth

Homeosoma ellectellum

Banded Sunflower Moth

Cochylis hospes

Argentine Looper

Rachiplusia nu

Spilosoma

Spilosoma virginica

Bertha Armyworm

Mamestra configurata

Diamondback Moth

Plutella xylostells

Diamondback Moth resistant

Plutella xylostells

to Cry1A-class of toxins

COLEOPTERA

Red Sunflower Seed Weevil

Smicronyx fulvus

Sunflower Stem Weevil

Cylindrocopturus adspersus

Sunflower Beetle

Zygoramma exclamationis

Canola Flea Beetle

Phyllotreta cruciferae

Western Corn Rootworm

Diabrotica virgifera virgifera

DIPTERA

Hessian Fly

Mayetiola destructor

HOMOPTERA

Greenbug

Schizaphis graminum

HEMIPTERA

Lygus Bug

Lygus lineolaris

NEMATODA

Heterodera glycines

EXAMPLE 14

Insertion of Toxin Genes Into Plants

One aspect of the subject invention is the transformation of plants with genes encoding the insecticidal toxin of the present invention. The transformed plants are resistant to attack by the target pest.

Genes encoding pesticidal toxins, as disclosed herein, can be inserted into plant cells using a variety of techniques which are well known in the art. For example, a large number of cloning vectors comprising a replication system in

E. coli

and a marker that permits selection of the transformed cells are available for preparation for the insertion of foreign genes into higher plants. The vectors comprise, for example, pBR322, pUC series, M13mp series, pACYC184, etc. Accordingly, the sequence encoding the Bacillus toxin can be inserted into the vector at a suitable restriction site. The resulting plasmid is used for transformation into

E. coli

. The

E. coli

cells are cultivated in a suitable nutrient medium, then harvested and lysed. The plasmid is recovered. Sequence analysis, restriction analysis, electrophoresis, and other biochemical-molecular biological methods are generally carried out as methods of analysis. After each manipulation, the DNA sequence used can be cleaved and joined to the next DNA sequence. Each plasmid sequence can be cloned in the same or other plasmids. Depending on the method of inserting desired genes into the plant, other DNA sequences may be necessary. If, for example, the Ti or Ri plasmid is used for the transformation of the plant cell, then at least the right border, but often the right and the left border of the Ti or Ri plasmid T-DNA, has to be joined as the flanking region of the genes to be inserted.

The use of T-DNA for the transformation of plant cells has been intensively researched and sufficiently described in EP 120 516; Hoekema (1985) In:

The Binary Plant Vector System

, Offset-durkkerij Kanters B. V., Alblasserdam, Chapter 5; Fraley et al.,

Crit. Rev. Plant Sci

. 4:1-46; and An et al. (1985)

EMBO J

4:277-287.

Once the inserted DNA has been integrated in the genome, it is relatively stable there and, as a rule, does not come out again. It normally contains a selection marker that confers on the transformed plant cells resistance to a biocide or an antibiotic, such as kanamycin, G 418, bleomycin, hygromycin, or chloramphenicol, inter alia. The individually employed marker should accordingly permit the selection of transformed cells rather than cells that do not contain the inserted DNA.

A large number of techniques are available for inserting DNA into a plant host cell. Those techniques include transformation with T-DNA using

Agrobacterium tumefaciens

or

Agrobacterium rhizogenes

as transformation agent, fusion, injection, biolistics (microparticle bombardment), or electroporation as well as other possible methods. If Agrobacteria are used for the transformation, the DNA to be inserted has to be cloned into special plasmids, namely either into an intermediate vector or into a binary vector. The intermediate vectors can be integrated into the Ti or Ri plasmid by homologous recombination owing to sequences that are homologous to sequences in the T-DNA. The Ti or Ri plasmid also comprises the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate themselves in Agrobacteria. The intermediate vector can be transferred into

Agrobacterium tumefaciens

by means of a helper plasmid (conjugation). Binary vectors can replicate themselves both in

E. coli

and in Agrobacteria. They comprise a selection marker gene and a linker or polylinker which are framed by the right and left T-DNA border regions. They can be transformed directly into Agrobacteria (Holsters et al. [1978

] Mol. Gen. Genet

. 163:181-187). The Agrobacterium used as host cell is to comprise a plasmid carrying a vir region. The vir region is necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be contained. The bacterium so transformed is used for the transformation of plant cells. Plant explants can advantageously be cultivated with

Agrobacterium tumefaciens

or

Agrobacterium rhizogenes

for the transfer of the DNA into the plant cell. Whole plants can then be regenerated from the infected plant material (for example, pieces of leaf, segments of stalk, roots, but also protoplasts or suspension-cultivated cells) in a suitable medium, which may contain antibiotics or biocides for selection. The plants so obtained can then be tested for the presence of the inserted DNA. No special demands are made of the plasmids in the case of injection and electroporation. It is possible to use ordinary plasmids, such as, for example, pUC derivatives. In biolistic transformation, plasmid DNA or linear DNA can be employed.

The transformed cells are regenerated into morphologically normal plants in the usual manner. If a transformation event involves a germ line cell, then the inserted DNA and corresponding phenotypic trait(s) will be transmitted to progeny plants. Such plants can be grown in the normal manner and crossed with plants that have the same transformed hereditary factors or other hereditary factors. The resulting hybrid individuals have the corresponding phenotypic properties.

In a preferred embodiment of the subject invention, plants will be transformed with genes wherein the codon usage has been optimized for plants. See, for example, U.S. Pat. No. 5,380,831. Also, advantageously, plants encoding a truncated toxin will be used. The truncated toxin typically will encode about 55% to about 80% of the full length toxin. Methods for creating synthetic Bacillus genes for use in plants are known in the art.

It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and of the appended claims.

2375 base pairs

nucleic acid

single

linear

DNA (genomic)

Jav90

1
ATGAACAAGA ATAATACTAA ATTAAGCACA AGAGCCTTAC CAAGTTTTAT TGATTATTTT 60
AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAACATGAT TTTTAAAACG 120
GATACAGGTG GTGATCTAAC CCTAGACGAA ATTTTAAAGA ATCAGCAGTT ACTAAATGAT 180
ATTTCTGGTA AATTGGATGG GGTGAATGGA AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240
TTAAATACAG AATTATCTAA GGAAATATTA AAAATTGCAA ATGAACAAAA TCAAGTTTTA 300
AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCGGGTATA TCTACCTAAA 360
ATTACCTCTA TGTTGAGTGA TGTAATGAAA CAAAATTATG CGCTAAGTCT GCAAATAGAA 420
TACTTAAGTA AACAATTGCA AGAGATTTCT GATAAGTTGG ATATTATTAA TGTAAATGTA 480
CTTATTAACT CTACACTTAC TGAAATTACA CCTGCGTATC AAAGGATTAA ATATGTGAAC 540
GAAAAATTTG AGGAATTAAC TTTTGCTACA GAAACTAGTT CAAAAGTAAA AAAGGATGGC 600
TCTCCTGCAG ATATTCTTGA TGAGTTAACT GAGTTAACTG AACTAGCGAA AAGTGTAACA 660
AAAAATGATG TGGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720
AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCATCGG AATTAATTAC TAAAGAAAAT 780
GTGAAAACAA GTGGCAGTGA GGTCGGAAAT GTTTATAACT TCTTAATTGT ATTAACAGCT 840
CTGCAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 900
ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960
AACATCCTCC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020
AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GACATGCATT GATTGGGTTT 1080
GAAATTAGTA ATGATTCAAT TACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 1140
TATCAAGTCG ATAAGGATTC CTTATCGGAA GTTATTTATG GTGATATGGA TAAATTATTG 1200
TGCCCAGATC AATCTGAACA AATCTATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 1260
GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 1320
AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAAAGT AGAATCAAGT 1380
GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGGG TGTATATGCC GTTAGGTGTC 1440
ATCAGTGAAA CATTTTTGAC TCCGATTAAT GGGTTTGGCC TCCAAGCTGA TGAAAATTCA 1500
AGATTAATTA CTTTAACATG TAAATCATAT TTAAGAGAAC TACTGCTAGC AACAGACTTA 1560
AGCAATAAAG AAACTAAATT GATYGTCCCG CCAAGTGGTT TTATTAGCAA TATTGTAGAG 1620
AACGGGTCCA TAGAAGAGGA CAATTTAGAG CCGTGGAAAG CAAATAATAA GAATGCGTAT 1680
GTAGATCATA CAGGCGGAGT GAATGGAACT AAAGCTTTAT ATGTTCATAA GGACGGAGGA 1740
ATTTCACAAT TTATTGGAGA TAAGTTAAAA CCGAAAACTG AGTATGTAAT CCAATATACT 1800
GTTAAAGGAA AACCTTCTAT TCATTTAAAA GATGAAAATA CTGGATATAT TCATTATGAA 1860
GATACAAATA ATAATTTAGA AGATTATCAA ACTATTAATA AACGTTTTAC TACAGGAACT 1920
GATTTAAAGG GAGTGTATTT AATTTTAAAA AGTCAAAATG GAGATGAAGC TTGGGGAGAT 1980
AACTTTATTA TTTTGGAAAT TAGTCCTTCT GAAAAGTTAT TAAGTCCAGA ATTAATTAAT 2040
ACAAATAATT GGACGAGTAC GGGATCAACT AATATTAGCG GTAATACACT CACTCTTTAT 2100
CAGGGAGGAC GAGGGATTCT AAAACAAAAC CTTCAATTAG ATAGTTTTTC AACTTATAGA 2160
GTGTATTTTT CTGTGTCCGG AGATGCTAAT GTAAGGATTA GAAATTCTAG GGAAGTGTTA 2220
TTTGAAAAAA GATATATGAG CGGTGCTAAA GATGTTTCTG AAATGTTCAC TACAAAATTT 2280
GAGAAAGATA ACTTTTATAT AGAGCTTTCT CAAGGGAATA ATTTATATGG TGGTCCTATT 2340
GTACATTTTT ACGATGTCTC TATTAAGTAA CCCAA 2375

790 amino acids

amino acid

single

linear

protein

Jav90

2
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe
1 5 10 15
Ile Asp Tyr Phe Asn Gly Ile Tyr Gly Phe Ala Thr Gly Ile Lys Asp
20 25 30
Ile Met Asn Met Ile Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu
35 40 45
Asp Glu Ile Leu Lys Asn Gln Gln Leu Leu Asn Asp Ile Ser Gly Lys
50 55 60
Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu Ile Ala Gln Gly Asn
65 70 75 80
Leu Asn Thr Glu Leu Ser Lys Glu Ile Leu Lys Ile Ala Asn Glu Gln
85 90 95
Asn Gln Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala Ile Asn Thr
100 105 110
Met Leu Arg Val Tyr Leu Pro Lys Ile Thr Ser Met Leu Ser Asp Val
115 120 125
Met Lys Gln Asn Tyr Ala Leu Ser Leu Gln Ile Glu Tyr Leu Ser Lys
130 135 140
Gln Leu Gln Glu Ile Ser Asp Lys Leu Asp Ile Ile Asn Val Asn Val
145 150 155 160
Leu Ile Asn Ser Thr Leu Thr Glu Ile Thr Pro Ala Tyr Gln Arg Ile
165 170 175
Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr
180 185 190
Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp Ile Leu Asp Glu
195 200 205
Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val
210 215 220
Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly
225 230 235 240
Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu Ile
245 250 255
Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr
260 265 270
Asn Phe Leu Ile Val Leu Thr Ala Leu Gln Ala Lys Ala Phe Leu Thr
275 280 285
Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp Ile Asp Tyr Thr
290 295 300
Ser Ile Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val
305 310 315 320
Asn Ile Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala
325 330 335
Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met Ile Val Glu Ala Lys
340 345 350
Pro Gly His Ala Leu Ile Gly Phe Glu Ile Ser Asn Asp Ser Ile Thr
355 360 365
Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gln Asn Tyr Gln Val Asp
370 375 380
Lys Asp Ser Leu Ser Glu Val Ile Tyr Gly Asp Met Asp Lys Leu Leu
385 390 395 400
Cys Pro Asp Gln Ser Glu Gln Ile Tyr Tyr Thr Asn Asn Ile Val Phe
405 410 415
Pro Asn Glu Tyr Val Ile Thr Lys Ile Asp Phe Thr Lys Lys Met Lys
420 425 430
Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly
435 440 445
Glu Ile Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr
450 455 460
Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val
465 470 475 480
Ile Ser Glu Thr Phe Leu Thr Pro Ile Asn Gly Phe Gly Leu Gln Ala
485 490 495
Asp Glu Asn Ser Arg Leu Ile Thr Leu Thr Cys Lys Ser Tyr Leu Arg
500 505 510
Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu Ile
515 520 525
Val Pro Pro Ser Gly Phe Ile Ser Asn Ile Val Glu Asn Gly Ser Ile
530 535 540
Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr
545 550 555 560
Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His
565 570 575
Lys Asp Gly Gly Ile Ser Gln Phe Ile Gly Asp Lys Leu Lys Pro Lys
580 585 590
Thr Glu Tyr Val Ile Gln Tyr Thr Val Lys Gly Lys Pro Ser Ile His
595 600 605
Leu Lys Asp Glu Asn Thr Gly Tyr Ile His Tyr Glu Asp Thr Asn Asn
610 615 620
Asn Leu Glu Asp Tyr Gln Thr Ile Asn Lys Arg Phe Thr Thr Gly Thr
625 630 635 640
Asp Leu Lys Gly Val Tyr Leu Ile Leu Lys Ser Gln Asn Gly Asp Glu
645 650 655
Ala Trp Gly Asp Asn Phe Ile Ile Leu Glu Ile Ser Pro Ser Glu Lys
660 665 670
Leu Leu Ser Pro Glu Leu Ile Asn Thr Asn Asn Trp Thr Ser Thr Gly
675 680 685
Ser Thr Asn Ile Ser Gly Asn Thr Leu Thr Leu Tyr Gln Gly Gly Arg
690 695 700
Gly Ile Leu Lys Gln Asn Leu Gln Leu Asp Ser Phe Ser Thr Tyr Arg
705 710 715 720
Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg Ile Arg Asn Ser
725 730 735
Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val
740 745 750
Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr Ile Glu
755 760 765
Leu Ser Gln Gly Asn Asn Leu Tyr Gly Gly Pro Ile Val His Phe Tyr
770 775 780
Asp Val Ser Ile Lys Pro
785 790

20 base pairs

nucleic acid

single

linear

DNA (genomic)

3
GGRTTAMTTG GRTAYTATTT 20

20 base pairs

nucleic acid

single

linear

DNA (genomic)

4
ATATCKWAYA TTKGCATTTA 20

1042 base pairs

nucleic acid

single

linear

DNA (genomic)

66D3

5
TTAATTGGGT ACTATTTTAA AGGAAAAGAT TTTAATAATC TTACTATATT TGCTCCAACA 60
CGTGAGAATA CTCTTATTTA TGATTTAGAA ACAGCGAATT CTTTATTAGA TAAGCAACAA 120
CAAACCTATC AATCTATTCG TTGGATCGGT TTAATAAAAA GCAAAAAAGC TGGAGATTTT 180
ACCTTTCAAT TATCGGATGA TGAGCATGCT ATTATAGAAA TCGATGGGAA AGTTATTTCG 240
CAAAAAGGCC AAAAGAAACA AGTTGTTCAT TTAGAAAAAG ATAAATTAGT TCCCATCAAA 300
ATTGAATATC AATCTGATAA AGCGTTAAAC CCAGATAGTC AAATGTTTAA AGAATTGAAA 360
TTATTTAAAA TAAATAGTCA AAAACAATCT CAGCAAGTGC AACAAGACGA ATTGAGAAAT 420
CCTGAATTTG GTAAAGAAAA AACTCAAACA TATTTAAAGA AAGCATCGAA AAGCAGCCTG 480
TTTAGCAATA AAAGTAAACG AGATATAGAT GAAGATATAG ATGAGGATAC AGATACAGAT 540
GGAGATGCCA TTCCTGATGT ATGGGAAGAA AATGGGTATA CCATCAAAGG AAGAGTAGCT 600
GTTAAATGGG ACGAAGGATT AGCTGATAAG GGATATAAAA AGTTTGTTTC CAATCCTTTT 660
AGACAGCACA CTGCTGGTGA CCCCTATAGT GACTATGAAA AGGCATCAAA AGATTTGGAT 720
TTATCTAATG CAAAAGAAAC ATTTAATCCA TTGGTGGCTG CTTTTCCAAG TGTCAATGTT 780
AGCTTGGAAA ATGTCACCAT ATCAAAAGAT GAAAATAAAA CTGCTGAAAT TGCGTCTACT 840
TCATCGAATA ATTGGTCCTA TACAAATACA GAGGGGGCAT CTATTGAAGC TGGAATTGGA 900
CCAGAAGGTT TGTTGTCTTT TGGAGTAAGT GCCAATTATC AACATTCTGA AACAGTGGCC 960
AAAGAGTGGG GTACAACTAA GGGAGACGCA ACACAATATA ATACAGCTTC AGCAGGATAT 1020
CTAAATGCCA ATGTACGATA TA 1042

347 amino acids

amino acid

single

linear

peptide

66D3

6
Leu Ile Gly Tyr Tyr Phe Lys Gly Lys Asp Phe Asn Asn Leu Thr Ile
1 5 10 15
Phe Ala Pro Thr Arg Glu Asn Thr Leu Ile Tyr Asp Leu Glu Thr Ala
20 25 30
Asn Ser Leu Leu Asp Lys Gln Gln Gln Thr Tyr Gln Ser Ile Arg Trp
35 40 45
Ile Gly Leu Ile Lys Ser Lys Lys Ala Gly Asp Phe Thr Phe Gln Leu
50 55 60
Ser Asp Asp Glu His Ala Ile Ile Glu Ile Asp Gly Lys Val Ile Ser
65 70 75 80
Gln Lys Gly Gln Lys Lys Gln Val Val His Leu Glu Lys Asp Lys Leu
85 90 95
Val Pro Ile Lys Ile Glu Tyr Gln Ser Asp Lys Ala Leu Asn Pro Asp
100 105 110
Ser Gln Met Phe Lys Glu Leu Lys Leu Phe Lys Ile Asn Ser Gln Lys
115 120 125
Gln Ser Gln Gln Val Gln Gln Asp Glu Leu Arg Asn Pro Glu Phe Gly
130 135 140
Lys Glu Lys Thr Gln Thr Tyr Leu Lys Lys Ala Ser Lys Ser Ser Leu
145 150 155 160
Phe Ser Asn Lys Ser Lys Arg Asp Ile Asp Glu Asp Ile Asp Glu Asp
165 170 175
Thr Asp Thr Asp Gly Asp Ala Ile Pro Asp Val Trp Glu Glu Asn Gly
180 185 190
Tyr Thr Ile Lys Gly Arg Val Ala Val Lys Trp Asp Glu Gly Leu Ala
195 200 205
Asp Lys Gly Tyr Lys Lys Phe Val Ser Asn Pro Phe Arg Gln His Thr
210 215 220
Ala Gly Asp Pro Tyr Ser Asp Tyr Glu Lys Ala Ser Lys Asp Leu Asp
225 230 235 240
Leu Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe Pro
245 250 255
Ser Val Asn Val Ser Leu Glu Asn Val Thr Ile Ser Lys Asp Glu Asn
260 265 270
Lys Thr Ala Glu Ile Ala Ser Thr Ser Ser Asn Asn Trp Ser Tyr Thr
275 280 285
Asn Thr Glu Gly Ala Ser Ile Glu Ala Gly Ile Gly Pro Glu Gly Leu
290 295 300
Leu Ser Phe Gly Val Ser Ala Asn Tyr Gln His Ser Glu Thr Val Ala
305 310 315 320
Lys Glu Trp Gly Thr Thr Lys Gly Asp Ala Thr Gln Tyr Asn Thr Ala
325 330 335
Ser Ala Gly Tyr Leu Asn Ala Asn Val Arg Tyr
340 345

2645 base pairs

nucleic acid

single

linear

DNA (genomic)

PS177C8a

7
ATGAAGAAGA AGTTAGCAAG TGTTGTAACG TGTACGTTAT TAGCTCCTAT GTTTTTGAAT 60
GGAAATGTGA ATGCTGTTTA CGCAGACAGC AAAACAAATC AAATTTCTAC AACACAGAAA 120
AATCAACAGA AAGAGATGGA CCGAAAAGGA TTACTTGGGT ATTATTTCAA AGGAAAAGAT 180
TTTAGTAATC TTACTATGTT TGCACCGACA CGTGATAGTA CTCTTATTTA TGATCAACAA 240
ACAGCAAATA AACTATTAGA TAAAAAACAA CAAGAATATC AGTCTATTCG TTGGATTGGT 300
TTGATTCAGA GTAAAGAAAC GGGAGATTTC ACATTTAACT TATCTGAGGA TGAACAGGCA 360
ATTATAGAAA TCAATGGGAA AATTATTTCT AATAAAGGGA AAGAAAAGCA AGTTGTCCAT 420
TTAGAAAAAG GAAAATTAGT TCCAATCAAA ATAGAGTATC AATCAGATAC AAAATTTAAT 480
ATTGACAGTA AAACATTTAA AGAACTTAAA TTATTTAAAA TAGATAGTCA AAACCAACCC 540
CAGCAAGTCC AGCAAGATGA ACTGAGAAAT CCTGAATTTA ACAAGAAAGA ATCACAGGAA 600
TTCTTAGCGA AACCATCGAA AATAAATCTT TTCACTCAAA AAATGAAAAG GGAAATTGAT 660
GAAGACACGG ATACGGATGG GGACTCTATT CCTGACCTTT GGGAAGAAAA TGGGTATACG 720
ATTCAAAATA GAATCGCTGT AAAGTGGGAC GATTCTYTAG CAAGTAAAGG GTATACGAAA 780
TTTGTTTCAA ATCCGCTAGA AAGTCACACA GTTGGTGATC CTTATACAGA TTATGAAAAG 840
GCAGCAAGAG ACCTAGATTT GTCAAATGCA AAGGAAACGT TTAACCCATT GGTAGCTGCT 900
TTTCCAAGTG TGAATGTTAG TATGGAAAAG GTGATATTAT CACCAAATGA AAATTTATCC 960
AATAGTGTAG AGTCTCATTC ATCCACGAAT TGGTCTTATA CAAATACAGA AGGTGCTTCT 1020
GTTGAAGCGG GGATTGGACC AAAAGGTATT TCGTTCGGAG TTAGCGTAAA CTATCAACAC 1080
TCTGAAACAG TTGCACAAGA ATGGGGAACA TCTACAGGAA ATACTTCGCA ATTCAATACG 1140
GCTTCAGCGG GATATTTAAA TGCAAATGTT CGATATAACA ATGTAGGAAC TGGTGCCATC 1200
TACGATGTAA AACCTACAAC AAGTTTTGTA TTAAATAACG ATACTATCGC AACTATTACG 1260
GCGAAATCTA ATTCTACAGC CTTAAATATA TCTCCTGGAG AAAGTTACCC GAAAAAAGGA 1320
CAAAATGGAA TCGCAATAAC ATCAATGGAT GATTTTAATT CCCATCCGAT TACATTAAAT 1380
AAAAAACAAG TAGATAATCT GCTAAATAAT AAACCTATGA TGTTGGAAAC AAACCAAACA 1440
GATGGTGTTT ATAAGATAAA AGATACACAT GGAAATATAG TAACTGGCGG AGAATGGAAT 1500
GGTGTCATAC AACAAATCAA GGCTAAAACA GCGTCTATTA TTGTGGATGA TGGGGAACGT 1560
GTAGCAGAAA AACGTGTAGC GGCAAAAGAT TATGAAAATC CAGAAGATAA AACACCGTCT 1620
TTAACTTTAA AAGATGCCCT GAAGCTTTCA TATCCAGATG AAATAAAAGA AATAGAGGGA 1680
TTATTATATT ATAAAAACAA ACCGATATAC GAATCGAGCG TTATGACTTA CTTAGATGAA 1740
AATACAGCAA AAGAAGTGAC CAAACAATTA AATGATACCA CTGGGAAATT TAAAGATGTA 1800
AGTCATTTAT ATGATGTAAA ACTGACTCCA AAAATGAATG TTACAATCAA ATTGTCTATA 1860
CTTTATGATA ATGCTGAGTC TAATGATAAC TCAATTGGTA AATGGACAAA CACAAATATT 1920
GTTTCAGGTG GAAATAACGG AAAAAAACAA TATTCTTCTA ATAATCCGGA TGCTAATTTG 1980
ACATTAAATA CAGATGCTCA AGAAAAATTA AATAAAAATC GTACTATTAT ATAAGTTTAT 2040
ATATGAAGTC AGAAAAAAAC ACACAATGTG AGATTACTAT AGATGGGGAG ATTTATCCGA 2100
TCACTACAAA AACAGTGAAT GTGAATAAAG ACAATTACAA AAGATTAGAT ATTATAGCTC 2160
ATAATATAAA AAGTAATCCA ATTTCTTCAA TTCATATTAA AACGAATGAT GAAATAACTT 2220
TATTTTGGGA TGATATTTCT ATAACAGATG TAGCATCAAT AAAACCGGAA AATTTAACAG 2280
ATTCAGAAAT TAAACAGATT TATAGTAGGT ATGGTATTAA GTTAGAAGAT GGAATCCTTA 2340
TTGATAAAAA AGGTGGGATT CATTATGGTG AATTTATTAA TGAAGCTAGT TTTAATATTG 2400
AACCATTGCA AAATTATGTG ACAAAATATA AAGTTACTTA TAGTAGTGAG TTAGGACAAA 2460
ACGTGAGTGA CACACTTGAA AGTGATAAAA TTTACAAGGA TGGGACAATT AAATTTGATT 2520
TTACAAAATA TAGTRAAAAT GAACAAGGAT TATTTTATGA CAGTGGATTA AATTGGGACT 2580
TTAAAATTAA TGCTATTACT TATGATGGTA AAGAGATGAA TGTTTTTCAT AGATATAATA 2640
AATAG 2645

881 amino acids

amino acid

single

linear

peptide

PS177C8a

8
Met Lys Lys Lys Leu Ala Ser Val Val Thr Cys Thr Leu Leu Ala Pro
1 5 10 15
Met Phe Leu Asn Gly Asn Val Asn Ala Val Tyr Ala Asp Ser Lys Thr
20 25 30
Asn Gln Ile Ser Thr Thr Gln Lys Asn Gln Gln Lys Glu Met Asp Arg
35 40 45
Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys Asp Phe Ser Asn Leu
50 55 60
Thr Met Phe Ala Pro Thr Arg Asp Ser Thr Leu Ile Tyr Asp Gln Gln
65 70 75 80
Thr Ala Asn Lys Leu Leu Asp Lys Lys Gln Gln Glu Tyr Gln Ser Ile
85 90 95
Arg Trp Ile Gly Leu Ile Gln Ser Lys Glu Thr Gly Asp Phe Thr Phe
100 105 110
Asn Leu Ser Glu Asp Glu Gln Ala Ile Ile Glu Ile Asn Gly Lys Ile
115 120 125
Ile Ser Asn Lys Gly Lys Glu Lys Gln Val Val His Leu Glu Lys Gly
130 135 140
Lys Leu Val Pro Ile Lys Ile Glu Tyr Gln Ser Asp Thr Lys Phe Asn
145 150 155 160
Ile Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu Phe Lys Ile Asp Ser
165 170 175
Gln Asn Gln Pro Gln Gln Val Gln Gln Asp Glu Leu Arg Asn Pro Glu
180 185 190
Phe Asn Lys Lys Glu Ser Gln Glu Phe Leu Ala Lys Pro Ser Lys Ile
195 200 205
Asn Leu Phe Thr Gln Lys Met Lys Arg Glu Ile Asp Glu Asp Thr Asp
210 215 220
Thr Asp Gly Asp Ser Ile Pro Asp Leu Trp Glu Glu Asn Gly Tyr Thr
225 230 235 240
Ile Gln Asn Arg Ile Ala Val Lys Trp Asp Asp Ser Leu Ala Ser Lys
245 250 255
Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Glu Ser His Thr Val Gly
260 265 270
Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu Asp Leu Ser
275 280 285
Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe Pro Ser Val
290 295 300
Asn Val Ser Met Glu Lys Val Ile Leu Ser Pro Asn Glu Asn Leu Ser
305 310 315 320
Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp Ser Tyr Thr Asn Thr
325 330 335
Glu Gly Ala Ser Val Glu Ala Gly Ile Gly Pro Lys Gly Ile Ser Phe
340 345 350
Gly Val Ser Val Asn Tyr Gln His Ser Glu Thr Val Ala Gln Glu Trp
355 360 365
Gly Thr Ser Thr Gly Asn Thr Ser Gln Phe Asn Thr Ala Ser Ala Gly
370 375 380
Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val Gly Thr Gly Ala Ile
385 390 395 400
Tyr Asp Val Lys Pro Thr Thr Ser Phe Val Leu Asn Asn Asp Thr Ile
405 410 415
Ala Thr Ile Thr Ala Lys Ser Asn Ser Thr Ala Leu Asn Ile Ser Pro
420 425 430
Gly Glu Ser Tyr Pro Lys Lys Gly Gln Asn Gly Ile Ala Ile Thr Ser
435 440 445
Met Asp Asp Phe Asn Ser His Pro Ile Thr Leu Asn Lys Lys Gln Val
450 455 460
Asp Asn Leu Leu Asn Asn Lys Pro Met Met Leu Glu Thr Asn Gln Thr
465 470 475 480
Asp Gly Val Tyr Lys Ile Lys Asp Thr His Gly Asn Ile Val Thr Gly
485 490 495
Gly Glu Trp Asn Gly Val Ile Gln Gln Ile Lys Ala Lys Thr Ala Ser
500 505 510
Ile Ile Val Asp Asp Gly Glu Arg Val Ala Glu Lys Arg Val Ala Ala
515 520 525
Lys Asp Tyr Glu Asn Pro Glu Asp Lys Thr Pro Ser Leu Thr Leu Lys
530 535 540
Asp Ala Leu Lys Leu Ser Tyr Pro Asp Glu Ile Lys Glu Ile Glu Gly
545 550 555 560
Leu Leu Tyr Tyr Lys Asn Lys Pro Ile Tyr Glu Ser Ser Val Met Thr
565 570 575
Tyr Leu Asp Glu Asn Thr Ala Lys Glu Val Thr Lys Gln Leu Asn Asp
580 585 590
Thr Thr Gly Lys Phe Lys Asp Val Ser His Leu Tyr Asp Val Lys Leu
595 600 605
Thr Pro Lys Met Asn Val Thr Ile Lys Leu Ser Ile Leu Tyr Asp Asn
610 615 620
Ala Glu Ser Asn Asp Asn Ser Ile Gly Lys Trp Thr Asn Thr Asn Ile
625 630 635 640
Val Ser Gly Gly Asn Asn Gly Lys Lys Gln Tyr Ser Ser Asn Asn Pro
645 650 655
Asp Ala Asn Leu Thr Leu Asn Thr Asp Ala Gln Glu Lys Leu Asn Lys
660 665 670
Asn Arg Asp Tyr Tyr Ile Ser Leu Tyr Met Lys Ser Glu Lys Asn Thr
675 680 685
Gln Cys Glu Ile Thr Ile Asp Gly Glu Ile Tyr Pro Ile Thr Thr Lys
690 695 700
Thr Val Asn Val Asn Lys Asp Asn Tyr Lys Arg Leu Asp Ile Ile Ala
705 710 715 720
His Asn Ile Lys Ser Asn Pro Ile Ser Ser Ile His Ile Lys Thr Asn
725 730 735
Asp Glu Ile Thr Leu Phe Trp Asp Asp Ile Ser Ile Thr Asp Val Ala
740 745 750
Ser Ile Lys Pro Glu Asn Leu Thr Asp Ser Glu Ile Lys Gln Ile Tyr
755 760 765
Ser Arg Tyr Gly Ile Lys Leu Glu Asp Gly Ile Leu Ile Asp Lys Lys
770 775 780
Gly Gly Ile His Tyr Gly Glu Phe Ile Asn Glu Ala Ser Phe Asn Ile
785 790 795 800
Glu Pro Leu Gln Asn Tyr Val Thr Lys Tyr Lys Val Thr Tyr Ser Ser
805 810 815
Glu Leu Gly Gln Asn Val Ser Asp Thr Leu Glu Ser Asp Lys Ile Tyr
820 825 830
Lys Asp Gly Thr Ile Lys Phe Asp Phe Thr Lys Tyr Ser Xaa Asn Glu
835 840 845
Gln Gly Leu Phe Tyr Asp Ser Gly Leu Asn Trp Asp Phe Lys Ile Asn
850 855 860
Ala Ile Thr Tyr Asp Gly Lys Glu Met Asn Val Phe His Arg Tyr Asn
865 870 875 880
Lys

1022 base pairs

nucleic acid

single

linear

DNA (genomic)

177I8

9
TGGATTAATT GGGTATTATT TCAAAGGAAA AGATTTTAAT AATCTTACTA TGTTTGCACC 60
GACACGTGAT AATACCCTTA TGTATGACCA ACAAACAGCG AATGCATTAT TAGATAAAAA 120
ACAACAAGAA TATCAGTCCA TTCGTTGGAT TGGTTTGATT CAGAGTAAAG AAACGGGCGA 180
TTTCACATTT AACTTATCAA AGGATGAACA GGCAATTATA GAAATCGATG GGAAAATCAT 240
TTCTAATAAA GGGAAAGAAA AGCAAGTTGT CCATTTAGAA AAAGAAAAAT TAGTTCCAAT 300
CAAAATAGAG TATCAATCAG ATACGAAATT TAATATTGAT AGTAAAACAT TTAAAGAACT 360
TAAATTATTT AAAATAGATA GTCAAAACCA ATCTCAACAA GTTCAACTGA GAAACCCTGA 420
ATTTAACAAA AAAGAATCAC AGGAATTTTT AGCAAAAGCA TCAAAAACAA ACCTTTTTAA 480
GCAAAAAATG AAAAGAGATA TTGATGAAGA TACGGATACA GATGGAGACT CCATTCCTGA 540
TCTTTGGGAA GAAAATGGGT ACACGATTCA AAATAAAGTT GCTGTCAAAT GGGATGATTC 600
GCTAGCAAGT AAGGGATATA CAAAATTTGT TTCGAATCCA TTAGACAGCC ACACAGTTGG 660
CGATCCCTAT ACTGATTATG AAAAGGCCGC AAGGGATTTA GATTTATCAA ATGCAAAGGA 720
AACGTTCAAC CCATTGGTAG CTGCTTTYCC AAGTGTGAAT GTTAGTATGG AAAAGGTGAT 780
ATTATCACCA AATGAAAATT TATCCAATAG TGTAGAGTCT CATTCATCCA CGAATTGGTC 840
TTATACGAAT ACAGAAGGAG CTTCCATTGA AGCTGGTGGC GGTCCATTAG GCCTTTCTTT 900
TGGAGTGAGT GTTAATTATC AACACTCTGA AACAGTTGCA CAAGAATGGG GAACATCTAC 960
AGGAAATACT TCACAATTCA ATACGGCTTC AGCGGGATAT TTAAATGCCA ATATACGATA 1020
TA 1022

340 amino acids

amino acid

single

linear

peptide

177I8

10
Gly Leu Ile Gly Tyr Tyr Phe Lys Gly Lys Asp Phe Asn Asn Leu Thr
1 5 10 15
Met Phe Ala Pro Thr Arg Asp Asn Thr Leu Met Tyr Asp Gln Gln Thr
20 25 30
Ala Asn Ala Leu Leu Asp Lys Lys Gln Gln Glu Tyr Gln Ser Ile Arg
35 40 45
Trp Ile Gly Leu Ile Gln Ser Lys Glu Thr Gly Asp Phe Thr Phe Asn
50 55 60
Leu Ser Lys Asp Glu Gln Ala Ile Ile Glu Ile Asp Gly Lys Ile Ile
65 70 75 80
Ser Asn Lys Gly Lys Glu Lys Gln Val Val His Leu Glu Lys Glu Lys
85 90 95
Leu Val Pro Ile Lys Ile Glu Tyr Gln Ser Asp Thr Lys Phe Asn Ile
100 105 110
Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu Phe Lys Ile Asp Ser Gln
115 120 125
Asn Gln Ser Gln Gln Val Gln Leu Arg Asn Pro Glu Phe Asn Lys Lys
130 135 140
Glu Ser Gln Glu Phe Leu Ala Lys Ala Ser Lys Thr Asn Leu Phe Lys
145 150 155 160
Gln Lys Met Lys Arg Asp Ile Asp Glu Asp Thr Asp Thr Asp Gly Asp
165 170 175
Ser Ile Pro Asp Leu Trp Glu Glu Asn Gly Tyr Thr Ile Gln Asn Lys
180 185 190
Val Ala Val Lys Trp Asp Asp Ser Leu Ala Ser Lys Gly Tyr Thr Lys
195 200 205
Phe Val Ser Asn Pro Leu Asp Ser His Thr Val Gly Asp Pro Tyr Thr
210 215 220
Asp Tyr Glu Lys Ala Ala Arg Asp Leu Asp Leu Ser Asn Ala Lys Glu
225 230 235 240
Thr Phe Asn Pro Leu Val Ala Ala Xaa Pro Ser Val Asn Val Ser Met
245 250 255
Glu Lys Val Ile Leu Ser Pro Asn Glu Asn Leu Ser Asn Ser Val Glu
260 265 270
Ser His Ser Ser Thr Asn Trp Ser Tyr Thr Asn Thr Glu Gly Ala Ser
275 280 285
Ile Glu Ala Gly Gly Gly Pro Leu Gly Leu Ser Phe Gly Val Ser Val
290 295 300
Asn Tyr Gln His Ser Glu Thr Val Ala Gln Glu Trp Gly Thr Ser Thr
305 310 315 320
Gly Asn Thr Ser Gln Phe Asn Thr Ala Ser Ala Gly Tyr Leu Asn Ala
325 330 335
Asn Ile Arg Tyr
340

1341 base pairs

nucleic acid

single

linear

DNA (genomic)

PS177C8a

11
ATGTTTATGG TTTCTAAAAA ATTACAAGTA GTTACTAAAA CTGTATTGCT TAGTACAGTT 60
TTCTCTATAT CTTTATTAAA TAATGAAGTG ATAAAAGCTG AACAATTAAA TATAAATTCT 120
CAAAGTAAAT ATACTAACTT GCAAAATCTA AAAATCACTG ACAAGGTAGA GGATTTTAAA 180
GAAGATAAGG AAAAAGCGAA AGAATGGGGG AAAGAAAAAG AAAAAGAGTG GAAACTAACT 240
GCTACTGAAA AAGGAAAAAT GAATAATTTT TTAGATAATA AAAATGATAT AAAGACAAAT 300
TATAAAGAAA TTACTTTTTC TATGGCAGGC TCATTTGAAG ATGAAATAAA AGATTTAAAA 360
GAAATTGATA AGATGTTTGA TAAAACCAAT CTATCAAATT CTATTATCAC CTATAAAAAT 420
GTGGAACCGA CAACAATTGG ATTTAATAAA TCTTTAACAG AAGGTAATAC GATTAATTCT 480
GATGCAATGG CACAGTTTAA AGAACAATTT TTAGATAGGG ATATTAAGTT TGATAGTTAT 540
CTAGATACGC ATTTAACTGC TCAACAAGTT TCCAGTAAAG AAAGAGTTAT TTTGAAGGTT 600
ACGGTTCCGA GTGGGAAAGG TTCTACTACT CCAACAAAAG CAGGTGTCAT TTTAAATAAT 660
AGTGAATACA AAATGCTCAT TGATAATGGG TATATGGTCC ATGTAGATAA GGTATCAAAA 720
GTGGTGAAAA AAGGGGTGGA GTGCTTACAA ATTGAAGGGA CTTTAAAAAA GAGTCTTGAC 780
TTTAAAAATG ATATAAATGC TGAAGCGCAT AGCTGGGGTA TGAAGAATTA TGAAGAGTGG 840
GCTAAAGATT TAACCGATTC GCAAAGGGAA GCTTTAGATG GGTATGCTAG GCAAGATTAT 900
AAAGAAATCA ATAATTATTT AAGAAATCAA GGCGGAAGTG GAAATGAAAA ACTAGATGCT 960
CAAATAAAAA ATATTTCTGA TGCTTTAGGG AAGAAACCAA TACCGGAAAA TATTACTGTG 1020
TATAGATGGT GTGGCATGCC GGAATTTGGT TATCAAATTA GTGATCCGTT ACCTTCTTTA 1080
AAAGATTTTG AAGAACAATT TTTAAATACA ATCAAAGAAG ACAAAGGATA TATGAGTACA 1140
AGCTTATCGA GTGAACGTCT TGCAGCTTTT GGATCTAGAA AAATTATATT ACGATTACAA 1200
GTTCCGAAAG GAAGTACGGG TGCGTATTTA AGTGCCATTG GTGGATTTGC AAGTGAAAAA 1260
GAGATCCTAC TTGATAAAGA TAGTAAATAT CATATTGATA AAGTAACAGA GGTAATTATT 1320
AAGGTGTTAA GCGATATGTA G 1341

446 amino acids

amino acid

single

linear

peptide

PS177C8a

12
Met Phe Met Val Ser Lys Lys Leu Gln Val Val Thr Lys Thr Val Leu
1 5 10 15
Leu Ser Thr Val Phe Ser Ile Ser Leu Leu Asn Asn Glu Val Ile Lys
20 25 30
Ala Glu Gln Leu Asn Ile Asn Ser Gln Ser Lys Tyr Thr Asn Leu Gln
35 40 45
Asn Leu Lys Ile Thr Asp Lys Val Glu Asp Phe Lys Glu Asp Lys Glu
50 55 60
Lys Ala Lys Glu Trp Gly Lys Glu Lys Glu Lys Glu Trp Lys Leu Thr
65 70 75 80
Ala Thr Glu Lys Gly Lys Met Asn Asn Phe Leu Asp Asn Lys Asn Asp
85 90 95
Ile Lys Thr Asn Tyr Lys Glu Ile Thr Phe Ser Met Ala Gly Ser Phe
100 105 110
Glu Asp Glu Ile Lys Asp Leu Lys Glu Ile Asp Lys Met Phe Asp Lys
115 120 125
Thr Asn Leu Ser Asn Ser Ile Ile Thr Tyr Lys Asn Val Glu Pro Thr
130 135 140
Thr Ile Gly Phe Asn Lys Ser Leu Thr Glu Gly Asn Thr Ile Asn Ser
145 150 155 160
Asp Ala Met Ala Gln Phe Lys Glu Gln Phe Leu Asp Arg Asp Ile Lys
165 170 175
Phe Asp Ser Tyr Leu Asp Thr His Leu Thr Ala Gln Gln Val Ser Ser
180 185 190
Lys Glu Arg Val Ile Leu Lys Val Thr Val Pro Ser Gly Lys Gly Ser
195 200 205
Thr Thr Pro Thr Lys Ala Gly Val Ile Leu Asn Asn Ser Glu Tyr Lys
210 215 220
Met Leu Ile Asp Asn Gly Tyr Met Val His Val Asp Lys Val Ser Lys
225 230 235 240
Val Val Lys Lys Gly Val Glu Cys Leu Gln Ile Glu Gly Thr Leu Lys
245 250 255
Lys Ser Leu Asp Phe Lys Asn Asp Ile Asn Ala Glu Ala His Ser Trp
260 265 270
Gly Met Lys Asn Tyr Glu Glu Trp Ala Lys Asp Leu Thr Asp Ser Gln
275 280 285
Arg Glu Ala Leu Asp Gly Tyr Ala Arg Gln Asp Tyr Lys Glu Ile Asn
290 295 300
Asn Tyr Leu Arg Asn Gln Gly Gly Ser Gly Asn Glu Lys Leu Asp Ala
305 310 315 320
Gln Ile Lys Asn Ile Ser Asp Ala Leu Gly Lys Lys Pro Ile Pro Glu
325 330 335
Asn Ile Thr Val Tyr Arg Trp Cys Gly Met Pro Glu Phe Gly Tyr Gln
340 345 350
Ile Ser Asp Pro Leu Pro Ser Leu Lys Asp Phe Glu Glu Gln Phe Leu
355 360 365
Asn Thr Ile Lys Glu Asp Lys Gly Tyr Met Ser Thr Ser Leu Ser Ser
370 375 380
Glu Arg Leu Ala Ala Phe Gly Ser Arg Lys Ile Ile Leu Arg Leu Gln
385 390 395 400
Val Pro Lys Gly Ser Thr Gly Ala Tyr Leu Ser Ala Ile Gly Gly Phe
405 410 415
Ala Ser Glu Lys Glu Ile Leu Leu Asp Lys Asp Ser Lys Tyr His Ile
420 425 430
Asp Lys Val Thr Glu Val Ile Ile Lys Val Leu Ser Asp Met
435 440 445

21 base pairs

nucleic acid

single

linear

DNA (genomic)

13
GCTGATGAAC CATTTAATGC C 21

22 base pairs

nucleic acid

single

linear

DNA (genomic)

14
CTCTTTAAAG TAGATACTAA GC 22

24 base pairs

nucleic acid

single

linear

DNA (genomic)

15
GATGAGAACT TATCAAATAG TATC 24

33 base pairs

nucleic acid

single

linear

DNA (genomic)

16
CGAATTCTTT ATTAGATAAG CAACAACAAA CCT 33

24 base pairs

nucleic acid

single

linear

DNA (genomic)

17
GTTATTTCGC AAAAAGGCCA AAAG 24

31 base pairs

nucleic acid

single

linear

DNA (genomic)

18
GAATATCAAT CTGATAAAGC GTTAAACCCA G 31

23 base pairs

nucleic acid

single

linear

DNA (genomic)

19
GCAGCYTGTT TAGCAATAAA AGT 23

20 base pairs

nucleic acid

single

linear

DNA (genomic)

20
CAAAGGAAGA GTAGCTGTTA 20

25 base pairs

nucleic acid

single

linear

DNA (genomic)

21
CAATGTTAGC TTGGAAAATG TCACC 25

22 base pairs

nucleic acid

single

linear

DNA (genomic)

22
GCTTAGTATC TACTTTAAAG AG 22

24 base pairs

nucleic acid

single

linear

DNA (genomic)

23
GATACTATTT GATAAGTTCT CATC 24

24 base pairs

nucleic acid

single

linear

DNA (genomic)

24
CTTTTGGCCT TTTTGCGAAA TAAC 24

31 base pairs

nucleic acid

single

linear

DNA (genomic)

25
CTGGGTTTAA CGCTTTATCA GATTGATATT C 31

23 base pairs

nucleic acid

single

linear

DNA (genomic)

26
ACTTTTATTG CTAAACARGC TGC 23

20 base pairs

nucleic acid

single

linear

DNA (genomic)

27
TAACAGCTAC TCTTCCTTTG 20

25 base pairs

nucleic acid

single

linear

DNA (genomic)

28
GGTGACATTT TCCAAGCTAA CATTG 25

21 base pairs

nucleic acid

single

linear

DNA (genomic)

29
CCAGTCCAAT GAACCTCTTA C 21

21 base pairs

nucleic acid

single

linear

DNA (genomic)

30
AGGGAACAAA CCTTCCCAAC C 21

20 base pairs

nucleic acid

single

linear

DNA (genomic)

31
CARMTAKTAA MTAGGGATAG 20

22 base pairs

nucleic acid

single

linear

DNA (genomic)

32
AGYTTCTATC GAAGCTGGGR ST 22

1035 base pairs

nucleic acid

single

linear

DNA (genomic)

33
GGGTTAATTG GGTATTATTT TAAAGGGAAA GATTTTAATA ATCTGACTAT GTTTGCACCA 60
ACCATAAATA ATACGCTTAT TTATGATCGG CAAACAGCAG ATACACTATT AAATAAGCAG 120
CAACAAGAGT TCAATTCTAT TCGATGGATT GGTTTAATAC AAAGTAAAGA AACAGGTGAC 180
TTTACATTCC AATTATCAGA TGATAAAAAT GCCATCATTG AAATAGATGG AAAAGTTGTT 240
TCTCGTAGAG GAGAAGATAA ACAAACTATC CATTTAGAAA AAGGAAAGAT GGTTCCAATC 300
AAAATTGAGT ACCAGTCCAA TGAACCTCTT ACTGTAGATA GTAAAGTATT TAACGATCTT 360
AAACTATTTA AAATAGATGG TCATAATCAA TCGCATCAAA TACAGCAAGA TGATTTGAAA 420
ATCCTGAATT TAATAAAAAG GAAACGAAAG AGCTTTTATC AAAAACAGCA AAAAGAACCT 480
TTTCTCTTCA AAACGGGGTT GAGAAGCGAT GAGGATGATG ATCTAGGATA CAGATGGTGA 540
TAGCATTCCT GGATAATTGG GAAATGAATG GATATACCAT TCAAACGAAA AATGGCAGTC 600
AAATGGGATG ATTCATTTGC AGAAAAAGGA TATACAAAAT TTGTTTCGAA TCCATATGAA 660
GCCCATACAG CAGGAGATCC TTATACCGAT TATGAAAAAG CAGCAAAAGA TATTCCTTTA 720
TCGAACGCAA AAGAAGCCTT TAATCCTCTT GTAGCTGCTT TTCCATCTGT CAATGTAGGA 780
TTAGAAAAAG TAGTAATTTC TAAAAATGAG GATATGAGTC AGGGTGTATC ATCCAGCACT 840
TCGAATAGTG CCTCTAATAC AAATTCAATT GGTGTTACCG TAGATGCTGG TTGGGAAGGT 900
TTGTTCCCTA AATTTGGTAT TTCAACTAAT TATCAAAACA CATGGACCAC TGCACAAGAA 960
TGGGGCTCTT CTAAAGAAGA TTCTACCCAT ATAAATGGAG CACAATCAGC CTTTTTAAAT 1020
GCAAATGTAC GATAT 1035

345 amino acids

amino acid

single

linear

protein

34
Gly Leu Ile Gly Tyr Tyr Phe Lys Gly Lys Asp Phe Asn Asn Leu Thr
1 5 10 15
Met Phe Ala Pro Thr Ile Asn Asn Thr Leu Ile Tyr Asp Arg Gln Thr
20 25 30
Ala Asp Thr Leu Leu Asn Lys Gln Gln Gln Glu Phe Asn Ser Ile Arg
35 40 45
Trp Ile Gly Leu Ile Gln Ser Lys Glu Thr Gly Asp Phe Thr Phe Gln
50 55 60
Leu Ser Asp Asp Lys Asn Ala Ile Ile Glu Ile Asp Gly Lys Val Val
65 70 75 80
Ser Arg Arg Gly Glu Asp Lys Gln Thr Ile His Leu Glu Lys Gly Lys
85 90 95
Met Val Pro Ile Lys Ile Glu Tyr Gln Ser Asn Glu Pro Leu Thr Val
100 105 110
Asp Ser Lys Val Phe Asn Asp Leu Lys Leu Phe Lys Ile Asp Gly His
115 120 125
Asn Gln Ser His Gln Ile Gln Gln Asp Asp Leu Lys Ile Leu Asn Leu
130 135 140
Ile Lys Arg Lys Arg Lys Ser Phe Tyr Gln Lys Gln Gln Lys Glu Pro
145 150 155 160
Phe Leu Phe Lys Thr Gly Leu Arg Ser Asp Glu Asp Asp Asp Leu Gly
165 170 175
Tyr Arg Trp Xaa Xaa His Ser Trp Ile Ile Gly Lys Xaa Met Asp Ile
180 185 190
Pro Phe Lys Arg Lys Met Ala Val Lys Trp Asp Asp Ser Phe Ala Glu
195 200 205
Lys Gly Tyr Thr Lys Phe Val Ser Asn Pro Tyr Glu Ala His Thr Ala
210 215 220
Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Lys Asp Ile Pro Leu
225 230 235 240
Ser Asn Ala Lys Glu Ala Phe Asn Pro Leu Val Ala Ala Phe Pro Ser
245 250 255
Val Asn Val Gly Leu Glu Lys Val Val Ile Ser Lys Asn Glu Asp Met
260 265 270
Ser Gln Gly Val Ser Ser Ser Thr Ser Asn Ser Ala Ser Asn Thr Asn
275 280 285
Ser Ile Gly Val Thr Val Asp Ala Gly Trp Glu Gly Leu Phe Pro Lys
290 295 300
Phe Gly Ile Ser Thr Asn Tyr Gln Asn Thr Trp Thr Thr Ala Gln Glu
305 310 315 320
Trp Gly Ser Ser Lys Glu Asp Ser Thr His Ile Asn Gly Ala Gln Ser
325 330 335
Ala Phe Leu Asn Ala Asn Val Arg Tyr
340 345

1037 base pairs

nucleic acid

single

linear

DNA (genomic)

35
GGGTTAATTG GGTATTATTT TAAAGGGAAA GATTTTAATA ATCTGACTAT GTTTGCACCA 60
ACCATAAATA ATACGCTTAT TTATGATCGG CAAACAGCAG ATACACTATT AAATAAGCAG 120
CAACAAGAGT TCAATTCTAT TCGATGGATT GGTTTAATAC AAAGTAAAGA AACAGGTGAC 180
TTTACATTCC AATTATCAGA TGATAAAAAT GCCATCATTG AAATAGATGG AAAAGTTGTT 240
TCTCGTAGAG GAGAAGATAA ACAAACTATC CATTTAGAAA AAGGAAAGAT GGTTCCAATC 300
AAAATTGAGT ACCAGTCCAA TGAACCTCTT ACTGTAGATA GTAAAGTATT TAACGATCTT 360
AAACTATTTA AAATAGATGG TCATAATCAA TCGCATCAAA TACAGCAAGA TGATTTGAAA 420
AATCCTGAAT TTAATAAAAA AGAAACGAAA GAGCTTTTAT CAAAAACAGC AAAAAGRAAC 480
CTTTTCTCTT CAAACGRRGT KGAGAAGCGA TGAGGATGAT RATCYTAGAT ACAGGTGGKG 540
ATAGCATTCC YKGATAATTG GGGAAATGAA WGGRTATACC ATTCAACSGA AAAATGGSAG 600
TCAAATGGGA TGATTCATTT GCGGAAAAAG GATATACAAA ATTTGTTTCG AATCCATATG 660
AAGCCCATAC AGCAGGAGAT CCTTATACCG ATTATGAAAA AGCAGCAAAA GATATTCCTT 720
TATCGAACGC AAAAGAAGCC TTTAATCCTC TTGTAGCTGC TTTTCCATCT GTCAATGTAG 780
GATTAGAAAA AGTAGTAATT TCTAAAAATG AGGATATGAG TCAGGGTGTA TCATCCAGCA 840
CTTCGAATAG TGCCTCTAAT ACAAATTCAA TTGGTGTTAC CGTAGATGCT GGTTGGGAAG 900
GTTTGTTCCC TAAATTTGGT ATTTCAACTA ATTATCAAAA CACATGGACC ACTGCACAAG 960
AATGGGGCTC TTCTAAAGAA GATTCTACCC ATATAAATGG AGCACAATCA GCCTTTTTAA 1020
ATGCAAATGT ACGATAT 1037

1048 base pairs

nucleic acid

single

linear

DNA (genomic)

36
TGGGTTAATT GGGTATTATT TTAAAGGGCA AGAGTTTAAT CATCTTACTT TGTTCGCACC 60
AACACGTGAT AATACCCTTA TTTATGATCA ACAAACAGCG AATTCCTTAT TAGATACCAA 120
GCAACAAGAA TATCAATCTA TTCGCTGGAT TGGTTTAATT CAAAGTAAAG AAACGGGTGA 180
TTTCACATTT AACTTATCAG ATGATCAACA TGCAATTATA GAAATCGATG GCAAAATCAT 240
TTCGCATAAA GGACAGAATA AACAAGTTGT TCACTTAGAA AAAGGAAAGT TAGTCCCGAT 300
AAAAATTGAG TATCAATCAG ATCAACTATT AAATAGGGAT AGTAACATCT TTAAAGAGTT 360
TAAATTATTC AAAGTAGATA GTCAGCAACA CGCTCACCAA GTTCAACTAG ACGAATTAAG 420
AAACCCTGCG TTTAATAAAA AGGAAACACA ACAATCTTAA GAAAAAGCAT CCAAAAACAA 480
TCTTTTTACA CCAGGGACAT TAAAAGGAAG ATACTGATGA TGATGATAAG GATAACAGGA 540
TGGGAGATTC TATTCCTGGA CCTTTTGGGG GAAGAAAATG GGTATACCAA TCCCAAAATA 600
AAATAGCTGG TCCAAGTGGG ATGTTCATTC GCCGCGAAAG GGTATACAAA TTTGTTTCTT 660
AATCCACTTG ATAGTCATAC AGTTGGAGAT CCCTATACGG ATTATGAAAA AGCAGCAAGA 720
GATTTAGACT TGGCCCAATG CAAAAGAAAC ATTTAACCCA TTAGTAGCTG CTTTTCCAAG 780
TGTGAATGTG AATTTGGAAA AAGTCATTTT ATCTAAAGAT GAAAATCTAT CCAATAGTGT 840
AGAGTCACAT TCCTCCACCA ACTGGTCTTA TACGAATACA GAAGGAGCTT CTATCGAAGC 900
TGGGGCTAAA CCAGAGGGTC CTACTTTTGG AGTGAGTGCT ACTTATCAAC ACTCTGAAAC 960
AGTTGCAAAA GAATGGGGAA CATCTACAGG AAATACCTCG CAATTTAATA CAGCTTCAGC 1020
AGGATATTTA AATGCAAATG TACGATAT 1048

1175 base pairs

nucleic acid

single

linear

DNA (genomic)

37
ACCTCTAGAT GCANGCTCGA GCGGCCGCCA GTGTGATGGA TATCTGCAGA ATTCGGATTA 60
CTTGGGTATT ATTTTAAAGG GAAAGAGTTT AATCATCTTA CTTTGTTCGC ACCAACACGT 120
GATAATACCC TTATTTATGA TCAACAAACA GCGAATTCCT TATTAGATAC CAAACAACAA 180
GAATATCAAT CTATTCGCTG GATTGGTTTG ATTCAAAGTA AAGAAACAGG TGATTTCACG 240
TTTAACTTAT CTGATGATCA AAATGCAATT ATAGAAATAG ATGGCAAAAT CATTTCGCAT 300
AAAGGACAGA ATAAACAAGT TGTTCACTTA GAAAAAGGAA AGTTAGTCCC GATAAAAATT 360
GAGTATCAAT CAGATCAGAT ATTAACTAGG GATAGTAACA TCTTTAAAGA GTTCAATTAT 420
TCAAAGTAGA TAGTCAAGCA ACACTCTCAC CAAAGTTCAA CTTAGGNCNG AATTAAGNAA 480
CCCTNGGATT TTAANTTNAA AAAAAGGAAC CCNCANCATT CTTTAGGAAA AAGCAGCAAN 540
AACCAAATCC TTTTTTACCA CAGGATATTG AAAAGGAGAT ACGGGNTNGA TGATGGATTG 600
ATACCGGGAT ACCAGTTGGG GNTTCTANTC CCTGACCTTT GGGGAAAGAA AATNGGTATA 660
CCNATCCCAA AANTTAAGCC AGCTGTCCAG GTGGGATGAT TCAATTCGCC CGCGAAAGGG 720
TATACCAAAA TTTGTTTCTT AATCCACTTG AGAGTCATAC AGTTGGAGAT CCCTATACGG 780
ATTATGAAAA AGCAGCAAGA GATTTAGACT TGGCCAATGC AAAAGAAACA TTTAACCCAT 840
TAGTAGCTGC TTTTCCAAGT GTGAATGTGA ATTTGGAAAA AGTAATATTA TCCCCAGATG 900
AGAATTTATC TAACAGTGTA GAATCTCATT CGTCTACAAA TTGGTCTTAT ACGAATACTG 960
AAGGAGCTTC TATCGAAGCT GGGGGTGGTC CATTAGGTAT TTCATTTGGA GTGAGTGCTA 1020
ATTATCAACA CTCTGAAACA GTTGCAAAAG AATGGGGAAC ATCTACAGGA AATACCTCGC 1080
AATTTAATAC AGCTTCAGCA GGATATTTAA ATGCCAATGG TCGATNTAAG CCGAATNCCA 1140
NCACACTGNC GGCCGTTAGT AGTGGCACCG AGCCC 1175

1030 base pairs

nucleic acid

single

linear

DNA (genomic)

38
GGRTTAMTTG GGTATTATTT TAAAGGGAAA GATTTTAATG ATCTTACTGT ATTTGCACCA 60
ACGCGTGGGA ATACTCTTGT ATATGATCAA CAAACAGCAA ATACATTACT AAATCAAAAA 120
CAACAAGACT TTCAGTCTAT TCGTTGGGTT GGTTTAATTC AAAGTAAAGA AGCAGGCGAT 180
TTTACATTTA ACTTATCAGA TGATGAACAT ACGATGATAG AAATCGATGG GAAAGTTATT 240
TCTAATAAAG GGAAAGAAAA ACAAGTTGTC CATTTAGAAA AAGGACAGTT CGTTTCTATC 300
AAAATAGAAT ATCAAGCTGA TGAACCATTT AATGCGGATA GTCAAACCTT TAAAAATTTG 360
AAACTCYTTA AAGTAGATAC TAAGCAACAG TCCCAGCAAA TTCAACTAGA TGAATTAAGA 420
AACCCTGRAA TTTAATAAAA AAGAAACACA AGAATTTCTA ACAAAAGCAA CAAAAACAAA 480
CCTTATTACT CAAAAAGTGA AGAGTACTAG GGATGAAGAC ACGGATACAG ATGGAGATTC 540
TATTCCAGAC ATTTGGGAAG AAAATGGGTA TACCATCCAA AATAAGATTG CCGTCAAATG 600
GGATGATTCA TTAGCAAGTA AAGGATATAC GAAATTTGTT TCAAACCCAC TAGATACTCA 660
CACGGTTGGA GATCCTTATA CAGATTATGA AAAAGCAGCA AGGGATTTAG ATTTGTCAAA 720
TGCAAAAGAA ACATTTAACC CATTAGTTGC GGCTTTTCCA AGTGTGAATG TGAGTATGGA 780
AAAAGTGATA TTGTCTCCAG ATGAGAACTT ATCAAATAGT ATCGAGTCTC ATTCATCTAC 840
GAATTGGTCG TATACGAATA CAGAAGGGGC TTCTATTGAA GCTGGTGGGG GAGCATTAGG 900
CCTATCTTTT GGTGTAAGTG CAAACTATCA ACATTCTGAA ACAGTTGGGT ATGAATGGGG 960
AACATCTACG GGAAATACTT CGCAATTTAA TACAGCTTCA GCGGGGTATT TAAATGCCAA 1020
TRTAMGATAT 1030

23 base pairs

nucleic acid

single

linear

DNA (genomic)

39
CACTCAAAAA ATGAAAAGGG AAA 23

19 base pairs

nucleic acid

single

linear

DNA (genomic)

40
CCGGTTTTAT TGATGCTAC 19

20 base pairs

nucleic acid

single

linear

DNA (genomic)

41
AGAACAATTT TTAGATAGGG 20

20 base pairs

nucleic acid

single

linear

DNA (genomic)

42
TCCCTAAAGC ATCAGAAATA 20

1170 base pairs

nucleic acid

single

linear

DNA (genomic)

43
ATGAAGAAAC AAATAGCAAG CGTTGTAACT TGTACGCTAT TAGCCCCTAT GCTTTTTAAT 60
GGAGATATGA ACGCTGCTTA CGCAGCTAGT CAAACAAAAC AAACACCTGC AGCTCAGGTA 120
AACCAAGAGA AAGAAGTAGA TCGAAAAGGA TTACTTGGCT ATTACTTTAA AGGGAAAGAT 180
TTTAATGATC TTACTGTATT TGCACCAACG CGTGGGAATA CTCTTGTATA TGATCAACAA 240
ACAGCAAATA CATTACTAAA TCAAAAACAA CAAGACTTTC AGTCTATTCG TTGGGTTGGT 300
TTAATTCAAA GTAAAGAAGC AGGCGATTTT ACATTTAACT TATCAGATGA TGAACATACG 360
ATGATAGAAA TCGATGGGAA AGTTATTTCT AATAAAGGGA AAGAAAAACA AGTTGTCCAT 420
TTAGAAAAAG GACAGTTCGT TTCTATAAAA TGATTCAGCT GATGAACCAT TTAATGCGGT 480
AGTAAACCTT TAAAAATTTG AAACTCTTTA AAGTAGATAC TAAGCAACAG TCCCAGCAAA 540
TTCAACTAGA TGAATTAAGA AACCCTGAAT TTAATAAAAA AGAAACACAA GAATTTCTAA 600
CAAAAGCAAC AAAAACAAAC CTTATTACTC AAAAAGTGAA GAGTACTAGG GATGAAGACA 660
CGGATACAGA TGGAGATTCT ATTCCAGACA TTTGGGAAGA AAATGGGTAT ACCATCCAAA 720
ATAAATTGCC GTCAAATGGG ATGATTCATT AGCAAGTAAA GGATATACGA AATTTGTTTC 780
AAACCCACTA GATACTCACA CGGTTGGAGA TCCTTATACA GATTATGAAA AAGCAGCAAG 840
GGATTTAGAT TTGTCAAATG CAAAAGAAAC ATTTAACCCA TTAGTTGCGG CTTTTCCAAG 900
TGTAATTGAG TATGGAAAAA GGATTTGTTC CAGATGAGAA CTTATCAAAT AGTATCGAGT 960
TCATTCATTC CTACAATTGG TCGATACGAA TACAGAAGGG GCTTCTATTG AAGCTGGTGG 1020
GGGAGCATTA GGCCTATCTT TTGGTGTAAG TGCAAACTAT CAACATTCTG AAACAGTTGG 1080
GTATGAATGG GGAACATCTA CGGGAAATAC TTCGCAATTT AATACAGCTT CAGCGGGGTA 1140
TTTAAATGCG AATGTTGCTA CAATAACGTG 1170

348 amino acids

amino acid

single

linear

protein

44
Met Lys Lys Gln Ile Ala Ser Val Val Thr Cys Thr Leu Leu Ala Pro
1 5 10 15
Met Leu Phe Asn Gly Asp Met Asn Ala Ala Tyr Ala Ala Ser Gln Thr
20 25 30
Lys Gln Thr Pro Ala Ala Gln Val Asn Gln Glu Lys Glu Val Asp Arg
35 40 45
Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys Asp Phe Asn Asp Leu
50 55 60
Thr Val Phe Ala Pro Thr Arg Gly Asn Thr Leu Val Tyr Asp Gln Gln
65 70 75 80
Thr Ala Asn Thr Leu Leu Asn Gln Lys Gln Gln Asp Phe Gln Ser Ile
85 90 95
Arg Trp Val Gly Leu Ile Gln Ser Lys Glu Ala Gly Asp Phe Thr Phe
100 105 110
Asn Leu Ser Asp Asp Glu His Thr Met Ile Glu Ile Asp Gly Lys Val
115 120 125
Ile Ser Asn Lys Gly Lys Glu Lys Gln Val Val His Leu Glu Lys Gly
130 135 140
Gln Phe Val Ser Xaa Lys Xaa Xaa Xaa Xaa Ala Asp Glu Pro Phe Asn
145 150 155 160
Ala Xaa Ser Xaa Thr Phe Lys Asn Leu Lys Leu Phe Lys Val Asp Thr
165 170 175
Lys Gln Gln Ser Gln Gln Ile Gln Leu Asp Glu Leu Arg Asn Pro Glu
180 185 190
Phe Asn Lys Lys Glu Thr Gln Glu Phe Leu Thr Lys Ala Thr Lys Thr
195 200 205
Asn Leu Ile Thr Gln Lys Val Lys Ser Thr Arg Asp Glu Asp Thr Asp
210 215 220
Thr Asp Gly Asp Ser Ile Pro Asp Ile Trp Glu Glu Asn Gly Tyr Thr
225 230 235 240
Ile Gln Asn Xaa Ile Ala Val Lys Trp Asp Asp Ser Leu Ala Ser Lys
245 250 255
Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Asp Thr His Thr Val Gly
260 265 270
Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu Asp Leu Ser
275 280 285
Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe Pro Ser Val
290 295 300
Asn Xaa Ser Met Glu Lys Xaa Ile Leu Xaa Pro Asp Glu Asn Leu Ser
305 310 315 320
Asn Ser Ile Glu Xaa His Ser Phe Leu Xaa Ile Gly Arg Ile Arg Ile
325 330 335
Gln Lys Gly Leu Leu Leu Lys Leu Val Gly Glu His
340 345

3 base pairs

nucleic acid

single

linear

DNA (genomic)

45
ATG 3

1 amino acids

amino acid

single

linear

protein

46
Met
1

2583 base pairs

nucleic acid

single

linear

DNA (genomic)

47
ATGACATATA TGAAAAAAAA GTTAGTTAGT GTTGTAACTT GCACGTTATT GGCTCCGATA 60
TTTTTGACTG GAAATGTACA TCCTGTTAAT GCAGACAGTA AAAAAAGTCA GCCTTCTACA 120
GCGCAGGAAA AACAAGAAAA GCCGGTTGAT CGAAAAGGGT TACTCGGCTA TTTTTTTAAA 180
GGGAAAGAGT TTAATCATCT TACTTTGTTC GCACCAACAC GTGATAATAC CCTTATTTAT 240
GATCAACAAA CAGCGAATTC CTTATTAGAT ACCAAACAAC AAGAATATCA ATCTATTCGC 300
TGGATTGGTT TGATTCAAAG TAAAGAAACA GGTGATTTCA CGTTTAACTT ATCTGATGAT 360
CAAAATGCAA TTATAGAAAT AGATGGCAAA ATCATTTCGC ATAAAGGACA GAATAAACAA 420
GTTGTTCACT TAGAAAAAGG AAAGTTAGTC CCGATAAAAA TTGAGTATCA ATCAGATCAG 480
ATATTAACTA GGGATAGTAA CATCTTTAAA GAGTTTCAAT TATTCAAAGT AGATAGTCAG 540
CAACACTCTC ACCAAGTTCA ACTAGACGAA TTAAGAAACC CTGATTTTAA TAAAAAAGAA 600
ACACAACAAT TCTTAGAAAA AGCAGCAAAA ACAAATCTTT TTACACAGAA TATGAAAAGA 660
GATACGGATG ATGATGATGA TACGGATACA GATGGAGATT CTATTCCTGA CCTTTGGGAA 720
GAAAATGGGT ATACCATCCA AAATAAAGTA GCTGTCAAGT GGGATGATTC ATTCGCCGCG 780
AAAGGGTATA CAAAATTTGT TTCTAATCCA CTTGAGAGTC ATACAGTTGG AGATCCCTAT 840
ACGGATTATG AAAAAGCAGC AAGAGATTTA GACTTGGCCA ATGCAAAAGA AACATTTAAC 900
CCATTAGTAG CTGCTTTTCC AAGTGTGAAT GTGAATTTGG AAAAAGTAAT ATTATCCCCA 960
GATGAGAATT TATCTAACAG TGTAGAATCT CATTCGTCTA CAAATTGGTC TTATACGAAT 1020
ACTGAAGGAG CTTCTATCGA AGCTGGGGGT GGTCCATTAG GTATTTCATT TGGAGTGAGT 1080
GCTAATTATC AACACTCTGA AACAGTTGCA AAAGAATGGG GAACATCTAC AGGAAATACC 1140
TCGCAATTTA ATACAGCTTC AGCAGGATAT TTGAATGCGA ATGTTCGATA CAATAATGTG 1200
GGAACAGGTG CGATTTATGA GGTGAAACCT ACAACAAGTT TTGTATTAGA TAAAGATACT 1260
GTAGCAACAA TTACCGCAAA ATCGAATTCG ACAGCTTTAA GTATATCTCC AGGAGAAAGT 1320
TATCCCAAAA AAGGACAAAA TGGAATTGCA ATTAATACAA TGGATGATTT TAATTCCCAT 1380
CCGATTACAT TAAATAAACA ACAATTAGAT CAACTATTAA ATAATAAACC TCTTATGTTA 1440
GAAACAAATC AGGCAGATGG TGTTTATAAA ATAAAGGATA CAAGCGGTAA TATTGTGACT 1500
GGTGGAGAAT GGAACGGTGT TATCCAACAA ATTCAAGCAA AAACAGCCTC TATTATCGTT 1560
GATACGGGAG AAAGTGTTTC AGAAAAGCGT GTCGCAGCAA AAGATTATGA TAATCCTGAG 1620
GATAAAACAC CTTCTTTATC TTTAAAAGAG GCACTTAAAC TTGGATATCC AGAAGAAATT 1680
AAAGAAAAAG ATGGATTGTT GTACTATAAG GACAAGCCAA TTTACGAATC TAGTGTTATG 1740
ACTTATCTAG ATGAGAATAC AGCCAAGGAA GTGGAAAAAC AATTACAGGA TACAACCGGA 1800
ATATATAAAG ATATCAATCA TTTATATGAT GTGAAATTAA CACCTACAAT GAATTTTACG 1860
ATTAAATTAG CTTCCTTATA TGATGGAGCT GAAAATAATG ATGTGAAGAA TGGTCCTATA 1920
GGACATTGGT ATTATACCTA TAATACAGGG GGAGGAAATA CTGGAAAACA CCAATATAGG 1980
TCTGCTAATC CCAGTGCAAA TGTAGTTTTA TCTTCTGAAG CGAAAAGTAA GTTAGATAAA 2040
AATACAAATT ACTACCTTAG TATGTATATG AAAGCTGAGT CTGATACAGA GCCTACAATA 2100
GAAGTAAGTG GTGAGAATTC TACGATAACG AGTAAAAAGG TAAAACTAAA CAGTGAGGGC 2160
TATCAAAGAG TAGATATTTT AGTGCCGAAT TCTGAAAGAA ATCCAATAAA TCAAATATAT 2220
GTAAGAGGAA ATAATACAAC AAATGTATAC TGGGATGATG TTTCAATTAC AAATATTTCA 2280
GCTATAAACC CAAAAACTTT AACAGATGAA GAAATTAAAG AAATATATAA AGATTTTAGT 2340
GAGTCTAAAG ACTGGCCTTG GTTCAATGAT GTTACGTTTA AAAATATTAA ACCATTAGAG 2400
AATTATGTAA AACAATATAG AGTTGATTTC TGGAATACTA ATAGTGATAG ATCATTTAAT 2460
AGGATTAAGG ACAGTTACCC AGTTAATGAA GATGGAAGTG TTAAAGTCAA CATGACAGAA 2520
TATAATGAAG GATATCCACT TAGAATTGAA TCCGCCTACC ATTTAAATAT TTCAGATCTA 2580
TAA 2583

860 amino acids

amino acid

single

linear

protein

48
Met Thr Tyr Met Lys Lys Lys Leu Val Ser Val Val Thr Cys Thr Leu
1 5 10 15
Leu Ala Pro Ile Phe Leu Thr Gly Asn Val His Pro Val Asn Ala Asp
20 25 30
Ser Lys Lys Ser Gln Pro Ser Thr Ala Gln Glu Lys Gln Glu Lys Pro
35 40 45
Val Asp Arg Lys Gly Leu Leu Gly Tyr Phe Phe Lys Gly Lys Glu Phe
50 55 60
Asn His Leu Thr Leu Phe Ala Pro Thr Arg Asp Asn Thr Leu Ile Tyr
65 70 75 80
Asp Gln Gln Thr Ala Asn Ser Leu Leu Asp Thr Lys Gln Gln Glu Tyr
85 90 95
Gln Ser Ile Arg Trp Ile Gly Leu Ile Gln Ser Lys Glu Thr Gly Asp
100 105 110
Phe Thr Phe Asn Leu Ser Asp Asp Gln Asn Ala Ile Ile Glu Ile Asp
115 120 125
Gly Lys Ile Ile Ser His Lys Gly Gln Asn Lys Gln Val Val His Leu
130 135 140
Glu Lys Gly Lys Leu Val Pro Ile Lys Ile Glu Tyr Gln Ser Asp Gln
145 150 155 160
Ile Leu Thr Arg Asp Ser Asn Ile Phe Lys Glu Phe Gln Leu Phe Lys
165 170 175
Val Asp Ser Gln Gln His Ser His Gln Val Gln Leu Asp Glu Leu Arg
180 185 190
Asn Pro Asp Phe Asn Lys Lys Glu Thr Gln Gln Phe Leu Glu Lys Ala
195 200 205
Ala Lys Thr Asn Leu Phe Thr Gln Asn Met Lys Arg Asp Thr Asp Asp
210 215 220
Asp Asp Asp Thr Asp Thr Asp Gly Asp Ser Ile Pro Asp Leu Trp Glu
225 230 235 240
Glu Asn Gly Tyr Thr Ile Gln Asn Lys Val Ala Val Lys Trp Asp Asp
245 250 255
Ser Phe Ala Ala Lys Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Glu
260 265 270
Ser His Thr Val Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg
275 280 285
Asp Leu Asp Leu Ala Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala
290 295 300
Ala Phe Pro Ser Val Asn Val Asn Leu Glu Lys Val Ile Leu Ser Pro
305 310 315 320
Asp Glu Asn Leu Ser Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp
325 330 335
Ser Tyr Thr Asn Thr Glu Gly Ala Ser Ile Glu Ala Gly Gly Gly Pro
340 345 350
Leu Gly Ile Ser Phe Gly Val Ser Ala Asn Tyr Gln His Ser Glu Thr
355 360 365
Val Ala Lys Glu Trp Gly Thr Ser Thr Gly Asn Thr Ser Gln Phe Asn
370 375 380
Thr Ala Ser Ala Gly Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val
385 390 395 400
Gly Thr Gly Ala Ile Tyr Glu Val Lys Pro Thr Thr Ser Phe Val Leu
405 410 415
Asp Lys Asp Thr Val Ala Thr Ile Thr Ala Lys Ser Asn Ser Thr Ala
420 425 430
Leu Ser Ile Ser Pro Gly Glu Ser Tyr Pro Lys Lys Gly Gln Asn Gly
435 440 445
Ile Ala Ile Asn Thr Met Asp Asp Phe Asn Ser His Pro Ile Thr Leu
450 455 460
Asn Lys Gln Gln Leu Asp Gln Leu Leu Asn Asn Lys Pro Leu Met Leu
465 470 475 480
Glu Thr Asn Gln Ala Asp Gly Val Tyr Lys Ile Lys Asp Thr Ser Gly
485 490 495
Asn Ile Val Thr Gly Gly Glu Trp Asn Gly Val Ile Gln Gln Ile Gln
500 505 510
Ala Lys Thr Ala Ser Ile Ile Val Asp Thr Gly Glu Ser Val Ser Glu
515 520 525
Lys Arg Val Ala Ala Lys Asp Tyr Asp Asn Pro Glu Asp Lys Thr Pro
530 535 540
Ser Leu Ser Leu Lys Glu Ala Leu Lys Leu Gly Tyr Pro Glu Glu Ile
545 550 555 560
Lys Glu Lys Asp Gly Leu Leu Tyr Tyr Lys Asp Lys Pro Ile Tyr Glu
565 570 575
Ser Ser Val Met Thr Tyr Leu Asp Glu Asn Thr Ala Lys Glu Val Glu
580 585 590
Lys Gln Leu Gln Asp Thr Thr Gly Ile Tyr Lys Asp Ile Asn His Leu
595 600 605
Tyr Asp Val Lys Leu Thr Pro Thr Met Asn Phe Thr Ile Lys Leu Ala
610 615 620
Ser Leu Tyr Asp Gly Ala Glu Asn Asn Asp Val Lys Asn Gly Pro Ile
625 630 635 640
Gly His Trp Tyr Tyr Thr Tyr Asn Thr Gly Gly Gly Asn Thr Gly Lys
645 650 655
His Gln Tyr Arg Ser Ala Asn Pro Ser Ala Asn Val Val Leu Ser Ser
660 665 670
Glu Ala Lys Ser Lys Leu Asp Lys Asn Thr Asn Tyr Tyr Leu Ser Met
675 680 685
Tyr Met Lys Ala Glu Ser Asp Thr Glu Pro Thr Ile Glu Val Ser Gly
690 695 700
Glu Asn Ser Thr Ile Thr Ser Lys Lys Val Lys Leu Asn Ser Glu Gly
705 710 715 720
Tyr Gln Arg Val Asp Ile Leu Val Pro Asn Ser Glu Arg Asn Pro Ile
725 730 735
Asn Gln Ile Tyr Val Arg Gly Asn Asn Thr Thr Asn Val Tyr Trp Asp
740 745 750
Asp Val Ser Ile Thr Asn Ile Ser Ala Ile Asn Pro Lys Thr Leu Thr
755 760 765
Asp Glu Glu Ile Lys Glu Ile Tyr Lys Asp Phe Ser Glu Ser Lys Asp
770 775 780
Trp Pro Trp Phe Asn Asp Val Thr Phe Lys Asn Ile Lys Pro Leu Glu
785 790 795 800
Asn Tyr Val Lys Gln Tyr Arg Val Asp Phe Trp Asn Thr Asn Ser Asp
805 810 815
Arg Ser Phe Asn Arg Ile Lys Asp Ser Tyr Pro Val Asn Glu Asp Gly
820 825 830
Ser Val Lys Val Asn Met Thr Glu Tyr Asn Glu Gly Tyr Pro Leu Arg
835 840 845
Ile Glu Ser Ala Tyr His Leu Asn Ile Ser Asp Leu
850 855 860

1356 base pairs

nucleic acid

single

linear

DNA (genomic)

49
ATGGTATCCA AAAAGTTACA ATTAGTCACA AAAACTTTAG TGTTTAGTAC AGTTTTGTCA 60
ATACCGTTAT TAAATAATAG TGAGATAAAA GCGGAACAAT TAAATATGAA TTCTCAAATT 120
AAATATCCTA ACTTCCAAAA TATAAATATC GCTGATAAGC CAGTAGATTT TAAAGAGGAT 180
AAAGAAAAAG CACGAGAATG GGGAAAAGAA AAAGAAAAAG AGTGGAAACT AACTGCTACT 240
GAAAAAGGGA AAATTAATGA TTTTTTAGAT GATAAAGATG GATTAAAAAC AAAATACAAA 300
GAAATTAATT TTTCTAAGAA TTTTGAATAT GAAACAGAGT TAAAACAGCT TGAAAAAATT 360
AATAGCATGC TAGATAAAGC AAATCTAACA AATTCAATTG TCACGTATAA AAACGTTGAG 420
CCTACAACAA TAGGATTCAA TCACTCTTTG ACTGATGGGA ATCAAATTAA TTCCGAAGCT 480
CAACAGAAGT TCAAGGAACA GTTTTTAGGA AATGATATTA AATTTGATAG TTATTTGGAT 540
ATGCACTTAA CTGAACAAAA TGTTTCCGGT AAAGAAAGGG TTATTTTAAA AGTTACAGTA 600
CTTAGTGGGA AAGGTTCTAC TCCAACAAAA GCAGGTGTTG TTTTAAATAA TAAAGAATAC 660
AAAATGTTGA TTGATAATGG ATATATACTA CATGTAGAAA ACATAACGAA AGTTGTAAAA 720
AAAGGACAGG AATGTTTACA AGTTGAAGGA ACGTTAAAAA AGAGCTTGGA CTTTAAAAAT 780
GATAGTGACG GTAAGGGAGA TTCCTGGGGA AAGAAAAATT ACAAGGAATG GTCTGATTCT 840
TTAACAAATG ATCAGAGAAA AGACTTAAAT GATTATGGTG CGCGAGGTTA TACCGAAATA 900
AATAAATATT TACGTGAAGG GGGTACCGGA AATACAGAGT TGGAGGAAAA AATTAAAAAT 960
ATTTCTGACG CACTAGAAAA GAATCCTATC CCTGAAAACA TTACTGTTTA TAGATATTGC 1020
GGAATGGCGG AATTTGGTTA TCCAATTCAA CCCGAGGCTC CCTCCGTACA AGATTTTGAA 1080
GAGAAATTTT TGGATAAAAT TAAGGAAGAA AAAGGATATA TGAGTACGAG CTTATCAAGT 1140
GATGCGACTT CTTTTGGCGC AAGAAAAATT ATCTTAAGAT TGCAGATACC AAAAGGAAGT 1200
TCAGGAGCAT ATGTAGCTGG TTTAGATGGA TTTAAACCAG CAGAGAAGGA GATTCTTATT 1260
GATAAGGGAA GCAAGTATCA TATTGATAAA GTAACAGAAG TAGTTGTGAA AGGTATTAGA 1320
AAACTCGTAG TAGATGCGAC ATTATTATTA AAATAA 1356

451 amino acids

amino acid

single

linear

DNA (genomic)

50
Met Val Ser Lys Lys Leu Gln Leu Val Thr Lys Thr Leu Val Phe Ser
1 5 10 15
Thr Val Leu Ser Ile Pro Leu Leu Asn Asn Ser Glu Ile Lys Ala Glu
20 25 30
Gln Leu Asn Met Asn Ser Gln Ile Lys Tyr Pro Asn Phe Gln Asn Ile
35 40 45
Asn Ile Ala Asp Lys Pro Val Asp Phe Lys Glu Asp Lys Glu Lys Ala
50 55 60
Arg Glu Trp Gly Lys Glu Lys Glu Lys Glu Trp Lys Leu Thr Ala Thr
65 70 75 80
Glu Lys Gly Lys Ile Asn Asp Phe Leu Asp Asp Lys Asp Gly Leu Lys
85 90 95
Thr Lys Tyr Lys Glu Ile Asn Phe Ser Lys Asn Phe Glu Tyr Glu Thr
100 105 110
Glu Leu Lys Gln Leu Glu Lys Ile Asn Ser Met Leu Asp Lys Ala Asn
115 120 125
Leu Thr Asn Ser Ile Val Thr Tyr Lys Asn Val Glu Pro Thr Thr Ile
130 135 140
Gly Phe Asn His Ser Leu Thr Asp Gly Asn Gln Ile Asn Ser Glu Ala
145 150 155 160
Gln Gln Lys Phe Lys Glu Gln Phe Leu Gly Asn Asp Ile Lys Phe Asp
165 170 175
Ser Tyr Leu Asp Met His Leu Thr Glu Gln Asn Val Ser Gly Lys Glu
180 185 190
Arg Val Ile Leu Lys Val Thr Val Leu Ser Gly Lys Gly Ser Thr Pro
195 200 205
Thr Lys Ala Gly Val Val Leu Asn Asn Lys Glu Tyr Lys Met Leu Ile
210 215 220
Asp Asn Gly Tyr Ile Leu His Val Glu Asn Ile Thr Lys Val Val Lys
225 230 235 240
Lys Gly Gln Glu Cys Leu Gln Val Glu Gly Thr Leu Lys Lys Ser Leu
245 250 255
Asp Phe Lys Asn Asp Ser Asp Gly Lys Gly Asp Ser Trp Gly Lys Lys
260 265 270
Asn Tyr Lys Glu Trp Ser Asp Ser Leu Thr Asn Asp Gln Arg Lys Asp
275 280 285
Leu Asn Asp Tyr Gly Ala Arg Gly Tyr Thr Glu Ile Asn Lys Tyr Leu
290 295 300
Arg Glu Gly Gly Thr Gly Asn Thr Glu Leu Glu Glu Lys Ile Lys Asn
305 310 315 320
Ile Ser Asp Ala Leu Glu Lys Asn Pro Ile Pro Glu Asn Ile Thr Val
325 330 335
Tyr Arg Tyr Cys Gly Met Ala Glu Phe Gly Tyr Pro Ile Gln Pro Glu
340 345 350
Ala Pro Ser Val Gln Asp Phe Glu Glu Lys Phe Leu Asp Lys Ile Lys
355 360 365
Glu Glu Lys Gly Tyr Met Ser Thr Ser Leu Ser Ser Asp Ala Thr Ser
370 375 380
Phe Gly Ala Arg Lys Ile Ile Leu Arg Leu Gln Ile Pro Lys Gly Ser
385 390 395 400
Ser Gly Ala Tyr Val Ala Gly Leu Asp Gly Phe Lys Pro Ala Glu Lys
405 410 415
Glu Ile Leu Ile Asp Lys Gly Ser Lys Tyr His Ile Asp Lys Val Thr
420 425 430
Glu Val Val Val Lys Gly Ile Arg Lys Leu Val Val Asp Ala Thr Leu
435 440 445
Leu Leu Lys
450

47 base pairs

nucleic acid

single

linear

DNA (genomic)

51
GCTCTAGAAG GAGGTAACTT ATGAACAAGA ATAATACTAA ATTAAGC 47

27 base pairs

nucleic acid

single

linear

DNA (genomic)

52
GGGGTACCTT ACTTAATAGA GACATCG 27

2364 base pairs

nucleic acid

single

linear

DNA (genomic)

53
ATGAATATGA ATAATACTAA ATTAAACGCA AGGGCCCTAC CGAGTTTTAT TGATTATTTT 60
AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAATATGAT TTTTAAAACG 120
GATACAGGTG GTAATCTAAC CTTAGACGAA ATCCTAAAGA ATCAGCAGTT ACTAAATGAG 180
ATTTCTGGTA AATTGGATGG GGTAAATGGG AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240
TTAAATACAG AATTATCTAA GGAAATCTTA AAAATTGCAA ATGAACAGAA TCAAGTCTTA 300
AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCATATATA TCTACCTAAA 360
ATCACATCTA TGTTAAGTGA TGTAATGAAG CAAAATTATG CGCTAAGTCT GCAAGTAGAA 420
TACTTAAGTA AACAATTGAA AGAAATTTCT GATAAATTAG ATGTTATTAA CGTAAATGTT 480
CTTATTAACT CTACACTTAC TGAAATTACA CCTGCATATC AACGGATTAA ATATGTAAAT 540
GAAAAATTTG AAGAATTAAC TTTTGCTACA GAAACCACTT TAAAAGTAAA AAAGGATAGC 600
TCGCCTGCTG ATATTCTTGA CGAGTTAACT GAATTAACTG AACTAGCGAA AAGTGTTACA 660
AAAAATGACG TGGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720
AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCTTCAG AATTAATTGC TAAAGAAAAT 780
GTGAAAACAA GTGGCAGTGA AGTAGGAAAT GTTTATAATT TCTTAATTGT ATTAACAGCT 840
CTACAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 900
ATTGATTATA CATCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960
AACATCCTTC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020
AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GACATGCATT GGTTGGGTTT 1080
GAAATTAGTA ATGATTCAAT GACAGTATTA AAAGTATATG AAGCTAAGCT AAAACAAAAT 1140
TACCAAGTTG ATAAGGATTC CTTATCGGAA GTCATTTATA GTGATATGGA TAAATTATTG 1200
TGCCCAGATC AATCTGAACA AATTTATTAT ACAAATAATA TAGTATTTCC AAATGAATAT 1260
GTAATTACTA AAATTGATTT TACTAAGAAA ATGAAAACTT TAAGATATGA GGTAACAGCT 1320
AATTCTTACG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAGAAAGT AGAATCAAGT 1380
GAAGCGGAGT ATAGGACGTT AAGTGCTAAT AATGATGGAG TATATATGCC GTTAGGTGTC 1440
ATCAGTGAAA CATTTTTGAC TCCAATTAAT GGATTTGGCC TCCAAGCTGA TGAAAATTCA 1500
AGATTAATTA CTTTAACATG TAAATCATAT TTAAGGGAAC TACTACTAGC GACAGACTTA 1560
AGCAATAAAG AAACTAAATT GATTGTCCCG CCTATTAGTT TTATTAGTAA TATTGTAGAA 1620
AATGGGAACT TAGAGGGAGA AAACTTAGAG CCGTGGATAG CAAATAACAA AAATGCGTAT 1680
GTAGATCATA CAGGTGGTAT AAATGGAACT AAAGTTTTAT ATGTTCATAA GGATGGTGAG 1740
TTTTCACAAT TTGTTGGAGG TAAGTTAAAA TCGAAAACAG AATATGTAAT TCAATATATT 1800
GTAAAGGGAA AAGCTTCTAT TTATTTAAAA GATAAAAAAA ATGAGAATTC CATTTATGAA 1860
GAAATAAATA ATGATTTAGA AGGTTTTCAA ACTGTTACTA AACGTTTTAT TACAGGAACG 1920
GATTCTTCAG GGATTCATTT AATTTTTACC AGTCAAAATG GCGAGGGAGC ATTTGGAGGA 1980
AACTTTATTA TCTCAGAAAT TAGGACATCC GAAGAGTTAT TAAGTCCAGA ATTGATTATG 2040
TCGGATGCTT GGGTTGGATC CCAGGGAACT TGGATCTCAG GAAATTCTCT CACTATTAAT 2100
AGTAATGTAA ATGGAACCTT TCGACAAAAT CTTCCGTTAG AAAGTTATTC AACCTATAGT 2160
ATGAACTTTA CTGTGAATGG ATTTGGCAAG GTGACAGTAA GAAATTCTCG TGAAGTATTA 2220
TTTGAAAAAA GTTATCCGCA GCTTTCACCT AAAGATATTT CTGAAAAATT TACAACTGCA 2280
GCCAATAATA CCGGATTATA TGTAGAGCTT TCTCGCTCAA CGTCGGGTGG TGCAATAAAT 2340
TTCCGAGATT TTTCAATTAA GTAA 2364

787 amino acids

amino acid

single

linear

protein

54
Met Asn Met Asn Asn Thr Lys Leu Asn Ala Arg Ala Leu Pro Ser Phe
1 5 10 15
Ile Asp Tyr Phe Asn Gly Ile Tyr Gly Phe Ala Thr Gly Ile Lys Asp
20 25 30
Ile Met Asn Met Ile Phe Lys Thr Asp Thr Gly Gly Asn Leu Thr Leu
35 40 45
Asp Glu Ile Leu Lys Asn Gln Gln Leu Leu Asn Glu Ile Ser Gly Lys
50 55 60
Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu Ile Ala Gln Gly Asn
65 70 75 80
Leu Asn Thr Glu Leu Ser Lys Glu Ile Leu Lys Ile Ala Asn Glu Gln
85 90 95
Asn Gln Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala Ile Asn Thr
100 105 110
Met Leu His Ile Tyr Leu Pro Lys Ile Thr Ser Met Leu Ser Asp Val
115 120 125
Met Lys Gln Asn Tyr Ala Leu Ser Leu Gln Val Glu Tyr Leu Ser Lys
130 135 140
Gln Leu Lys Glu Ile Ser Asp Lys Leu Asp Val Ile Asn Val Asn Val
145 150 155 160
Leu Ile Asn Ser Thr Leu Thr Glu Ile Thr Pro Ala Tyr Gln Arg Ile
165 170 175
Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr
180 185 190
Thr Leu Lys Val Lys Lys Asp Ser Ser Pro Ala Asp Ile Leu Asp Glu
195 200 205
Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val
210 215 220
Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly
225 230 235 240
Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu Ile
245 250 255
Ala Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr
260 265 270
Asn Phe Leu Ile Val Leu Thr Ala Leu Gln Ala Lys Ala Phe Leu Thr
275 280 285
Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp Ile Asp Tyr Thr
290 295 300
Ser Ile Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val
305 310 315 320
Asn Ile Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala
325 330 335
Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met Ile Val Glu Ala Lys
340 345 350
Pro Gly His Ala Leu Val Gly Phe Glu Ile Ser Asn Asp Ser Met Thr
355 360 365
Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gln Asn Tyr Gln Val Asp
370 375 380
Lys Asp Ser Leu Ser Glu Val Ile Tyr Ser Asp Met Asp Lys Leu Leu
385 390 395 400
Cys Pro Asp Gln Ser Glu Gln Ile Tyr Tyr Thr Asn Asn Ile Val Phe
405 410 415
Pro Asn Glu Tyr Val Ile Thr Lys Ile Asp Phe Thr Lys Lys Met Lys
420 425 430
Thr Leu Arg Tyr Glu Val Thr Ala Asn Ser Tyr Asp Ser Ser Thr Gly
435 440 445
Glu Ile Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr
450 455 460
Arg Thr Leu Ser Ala Asn Asn Asp Gly Val Tyr Met Pro Leu Gly Val
465 470 475 480
Ile Ser Glu Thr Phe Leu Thr Pro Ile Asn Gly Phe Gly Leu Gln Ala
485 490 495
Asp Glu Asn Ser Arg Leu Ile Thr Leu Thr Cys Lys Ser Tyr Leu Arg
500 505 510
Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu Ile
515 520 525
Val Pro Pro Ile Ser Phe Ile Ser Asn Ile Val Glu Asn Gly Asn Leu
530 535 540
Glu Gly Glu Asn Leu Glu Pro Trp Ile Ala Asn Asn Lys Asn Ala Tyr
545 550 555 560
Val Asp His Thr Gly Gly Ile Asn Gly Thr Lys Val Leu Tyr Val His
565 570 575
Lys Asp Gly Glu Phe Ser Gln Phe Val Gly Gly Lys Leu Lys Ser Lys
580 585 590
Thr Glu Tyr Val Ile Gln Tyr Ile Val Lys Gly Lys Ala Ser Ile Tyr
595 600 605
Leu Lys Asp Lys Lys Asn Glu Asn Ser Ile Tyr Glu Glu Ile Asn Asn
610 615 620
Asp Leu Glu Gly Phe Gln Thr Val Thr Lys Arg Phe Ile Thr Gly Thr
625 630 635 640
Asp Ser Ser Gly Ile His Leu Ile Phe Thr Ser Gln Asn Gly Glu Gly
645 650 655
Ala Phe Gly Gly Asn Phe Ile Ile Ser Glu Ile Arg Thr Ser Glu Glu
660 665 670
Leu Leu Ser Pro Glu Leu Ile Met Ser Asp Ala Trp Val Gly Ser Gln
675 680 685
Gly Thr Trp Ile Ser Gly Asn Ser Leu Thr Ile Asn Ser Asn Val Asn
690 695 700
Gly Thr Phe Arg Gln Asn Leu Pro Leu Glu Ser Tyr Ser Thr Tyr Ser
705 710 715 720
Met Asn Phe Thr Val Asn Gly Phe Gly Lys Val Thr Val Arg Asn Ser
725 730 735
Arg Glu Val Leu Phe Glu Lys Ser Tyr Pro Gln Leu Ser Pro Lys Asp
740 745 750
Ile Ser Glu Lys Phe Thr Thr Ala Ala Asn Asn Thr Gly Leu Tyr Val
755 760 765
Glu Leu Ser Arg Ser Thr Ser Gly Gly Ala Ile Asn Phe Arg Asp Phe
770 775 780
Ser Ile Lys
785

Number	Name	Date	Kind
4448885	Schnepf et al.	May 1984	A
4467036	Schnepf et al.	Aug 1984	A
4797276	Herrnstadt et al.	Jan 1989	A
4853331	Herrnstadt et al.	Aug 1989	A
4918006	Ellar et al.	Apr 1990	A
4948734	Edwards et al.	Aug 1990	A
4990332	Payne et al.	Feb 1991	A
5039523	Payne et al.	Aug 1991	A
5093120	Edwards et al.	Mar 1992	A
5126133	Payne et al.	Jun 1992	A
5151363	Payne	Sep 1992	A
5164180	Payne et al.	Nov 1992	A
5169629	Payne et al.	Dec 1992	A
5236843	Narva et al.	Aug 1993	A
5262399	Hickle et al.	Nov 1993	A
5270448	Payne	Dec 1993	A
5281530	Sick et al.	Jan 1994	A
5322932	Narva et al.	Jun 1994	A
5426049	Sick et al.	Jun 1995	A
5439881	Narva et al.	Aug 1995	A
5667993	Feitelson et al.	Sep 1997	A
5670365	Feitelson	Sep 1997	A

Number	Date	Country
0359472	Mar 1990	EP
9404684	Mar 1994	WO
9405771	Mar 1994	WO
9421795	Sep 1994	WO
9424264	Oct 1994	WO
9605314	Feb 1996	WO
9610083	Apr 1996	WO
9818932	May 1998	WO

Plants and cells transformed with a nucleic acid from Bacillus thuringiensis strain KB59A4-6 encoding a novel SUP toxin

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

US Referenced Citations (22)

Foreign Referenced Citations (8)

Non-Patent Literature Citations (15)

Entry
Lazar et al, 1988, Mol. Cell. Biol. 8:1247-1252.*
Hill et al, 1998, Biochem. Biophys. Res. Comm. 244:573-577.*
Gaertner, F. H., Leo Kim (1988) “Current Applied Recombinant DNA Projects” TIBTECH 6(4):54-57.
Gaertner, F. H. (1989) “Cellular Delivery Systems for Insecticidal Proteins: Living and Non-Living Microorganisms” in Controlled Delivery of Crop Protection Agents, R.M. Wilkins, ed., Taylor and Francis, New York and London, pp. 245-255.
Couch, T.L. (1980) “Mosquito Pthogenicity of Bacillus thuringiensis var. israelensis” in Developments in Industrial Microbiology 22:61-76.
Beegle, C.C. (1978) “Use of Entomogenous Bacteria in Agroccosystems” in Developments in Industrial Microbiology 20:97-104.
Krieg, V.A., et al. (1983) “Bacillus thuringiensis var. tenebrionis, a new pathotype effective against larvae of Coleoptera” Z. Ang. Ent. 96:500-508. Abstract.
Hofte, H., H.R. Whiteley (1989) “Insecticidal Cyrstal Proteins of Bacillus thuringiensis” Microbiological Reviews 53(2): 242-255.
Shevelev, A.B., et al. (1993) “Primary Structure of cryX**, the Novel δ-endotoxin-related gene from Bacillus thuringiensis spp. galleriae” FEBS 336(1): 79-82.
Smulevitch, S.V., et al. (1991) “Nucleotide Sequence of a Novel δ-Endotoxin Gene crylg of Bacillus thuringiensis ssp. galleriae” FEBS 293(1-2):25-28.
Schnepf, H.E., H.R. Whiteley (1981) “Cloning and Expression of the Bacillus thuringiensis Crystal Protein Gene in Escheria coli” Proc. Natl. Acad. Sci. USA 78(5): 2893-2897.
Estruch, J.J., et al. (1996) “Vip3A, A Novel Bacillus thuringiensis Vegetative Insecticidal Protein with a Wide Spectrum of Activities Against Lepidopteran Insects” Proc. Natl. Acad. Sci. USA 93:5389-5394.
Carozzi, N.B., et al. (1991) “Prediction of Insecticidal Activity of Bacillus thuringiensis Strains by Polymerase Chain Reaction Product Profiles” Applied and Environmental Microbiology 57(11):3057-3061.
Asano, Shoji, Hidetaka Hori, Yunlong Cui (1994) “A Unique Activity in Bacillus thuringiensis Growth Medium” Appl. Entomol. Zool. 29(1):39-45.
Li, Jade (1992) “Bacterial Toxins” Current Opinion in Structural Biology 2:545-556.